B03XA01|Erythropoietin/Epoetin beta/|BH049|NEORECORMON|solution for injection, pre-filled syringe|10000|IU|6|60000|Roche Registration GmbH, |257.06|2|1|0|C|8|5||0|0.00428|1981|0|
B03XA01|Erythropoietine /human recombinant|BH050|Binocrit|SOL. INJ. PRE-FILLED SYRINGE|10000 IU|IU|6|60000|Sandoz GmbH, |257.06|2|1|0|C|8|5||0|0.00428|2991|0|
B03XA01|Erythropoietine /human recombinant|BH056|Retacrit|SOL. INJ. PRE-FILLED SYRINGE|10000 IU|IU|6|60000|Pfizer Europe MA EEIG, |257.06|2|1|0|C|8|5||0|0.00428|2992|0|
B03XA02|DARBEPOETIN ALFA|BH057|Aranesp|SOLUTION FOR INJECTION PREFILLED SYRINGE WITH NEEDLE GUARD|300 mcg/0,6 ml|mcg|1|300|Amgen Europe B.V., |338.15|3|1|0|C|8|5||0|1.12655|3462|0|
B03XA02|DARBEPOETIN ALFA|BH058|Aranesp|SOLUTION FOR INJECTION PREFILLED SYRINGE WITH NEEDLE GUARD|150 mcg/0,3 ml|mcg|1|150|Amgen Europe B.V., |169.05|3|1|0|C|8|5||0|1.12655|3461|0|
B03XA03|METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA|BH081|MIRCERA|SOL. INJ. PRE-FILLED SYRINGE|150 mcg/0,3 ml|mcg|1|150|Roche Registration GmbH, |190.2|3|1|0|C||5||0|1.26709|2721|0|
B02BB01|HUMAN FIBRINOGEN|BH087|Haemocomplettan P|POWD.FOR SOL. FOR INJ/INF|1 000 mg|mg|1|1000|CSL Behring GmbH, |423.43||||H|||||0.4232|3502||
B02BD01|COAGULATION FACTOR IX, II, VII AND X IN COMB.|BH088|OCTAPLEX|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, |173.19||||H|||||0.34638|3417||
B02BD01|COAGULATION FACTOR IX, II, VII AND X IN COMB.|BH089|Prothromplex Total NF|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|600IU|IU|1|600|Baxalta Innovations GmbH, |207.83||||H|||||0.34638|2753||
B02BD02|COAGULATION FACTOR VIII|BH090|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|1000IU|IU|1|1000|CSL Behring GmbH, |335.36||||H|||||0.30843|4047||
B02BD02|COAGULATION FACTOR VIII|BH091|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|250IU|IU|1|250|CSL Behring GmbH, |83.84||||H|||||0.30843|4045||
B02BD02|COAGULATION FACTOR VIII|BH092|Beriate|POWD. AND SOLV. FOR SOL. FOR INJECTION/INFUSION|500IU|IU|1|500|CSL Behring GmbH, |167.68||||H|||||0.30843|4046||
B02BD02|COAGULATION FACTOR VIII|BH093|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Instituto Grifols S.A., |167.68||||H|||||0.30843|903||
B02BD02|COAGULATION FACTOR VIII|BH094|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Instituto Grifols S.A., |83.09||||H|||||0.30843|902||
B02BD02|COAGULATION FACTOR VIII|BH095|Fanhdi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Instituto Grifols S.A., |332.34||||H|||||0.30843|904||
B02BD06|VON WILLEBRAND FACTOR AND COAG FACTORVIII IN COMB|BH096|Immunate|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Baxalta Innovations GmbH, |154.21||||H|||||0.30843|2441||
B02BD02|COAGULATION FACTOR VIII|BH097|OCTANATE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, |167.68||||H|||||0.30843|773||
B02BD02|COAGULATION FACTOR VIII|BH098|OCTANATE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Octapharma (IP) SPRL, |332.34||||H|||||0.30843|3650||
B02BD02|COAGULATION FACTOR VIII|BH099|Advate|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Takeda Manufacturing Austria AG, |235.81||||H|||||0.52673|4000||
B02BD02|COAGULATION FACTOR VIII|BH104|NovoEight|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Novo Nordisk A.S., |235.81||||H|||||0.52673|4038||
B02BD02|COAGULATION FACTOR VIII|BH105|Nuwiq|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma AB, |235.81||||H|||||0.52673|4082||
B02BD02|COAGULATION FACTOR VIII|BH106|ReFacto AF|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Pfizer Europe MA EEIG, |235.81||||H|||||0.52673|3640||
B02BD02|COAGULATION FACTOR VIII|BH108|Adynovi|POWDER AND SOLVENT FOR INJECTION|500IU|IU|1|500|Baxalta Innovations GmbH, |301.02||||H|||||0.60204|16387||
B02BD02|COAGULATION FACTOR VIII|BH110|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Swedish Orphan Biovitrum AB, |602.04||||H|||||0.60204|15668||
B02BD02|COAGULATION FACTOR VIII|BH111|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Swedish Orphan Biovitrum AB, |150.51||||H|||||0.60204|15666||
B02BD02|COAGULATION FACTOR VIII|BH112|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Swedish Orphan Biovitrum AB, |301.02||||H|||||0.60204|15667||
B02BD02|COAGULATION FACTOR VIII|BH113|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|3000 IU|IU|1|3000|Swedish Orphan Biovitrum AB, |1806.13||||H|||||0.60204|16051||
B02BD02|COAGULATION FACTOR VIII|BH114|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2000 IU|IU|1|2000|Swedish Orphan Biovitrum AB, |1204.09||||H|||||0.60204|16050||
B02BD02|COAGULATION FACTOR VIII|BH115|Elocta|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1500 IU|IU|1|1500|Swedish Orphan Biovitrum AB, |903.07||||H|||||0.60204|16049||
B02BD03|FACTOR VIII INHIBITOR BYPASSING ACTIVITY|BH116|Feiba|POWDER AND SOLVENT FOR SOLUTION FOR INFUSION|25 U/ml (500 U)|IU|1|500|Baxalta Innovations GmbH, |370.94||||H|||||0.74189|15828||
B02BD04|COAGULATION FACTOR IX|BH118|Aimafix|POWDER AND SOLVENT FOR SOLUTION FOR INFUSION|500IU|IU|1|500|Kedrion S.p.A., |196.14||||H|||||0.39226|369||
B02BD04|COAGULATION FACTOR IX|BH119|IMMUNINE|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION/INFUSION|600IU|IU|1|600|Baxalta Innovations GmbH, |235.36||||H|||||0.39226|2442||
B02BD04|COAGULATION FACTOR IX|BH120|OCTANINE F|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, |196.14||||H|||||0.39226|765||
B02BD04|COAGULATION FACTOR IX|BH121|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000IU|IU|1|1000|Swedish Orphan Biovitrum AB, |1030.21||||H|||||1.03367|15906||
B02BD04|COAGULATION FACTOR IX|BH122|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|3000 IU|IU|1|3000|Swedish Orphan Biovitrum AB, |3090.62||||H|||||1.03367|15908||
B02BD04|COAGULATION FACTOR IX|BH123|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2000 IU|IU|1|2000|Swedish Orphan Biovitrum AB, |2060.42||||H|||||1.03367|15907||
B02BD04|COAGULATION FACTOR IX|BH124|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Swedish Orphan Biovitrum AB, |515.11||||H|||||1.03367|15905||
B02BD04|COAGULATION FACTOR IX|BH125|Alprolix|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|Swedish Orphan Biovitrum AB, |257.55||||H|||||1.03367|15904||
B02BD04|COAGULATION FACTOR IX|BH126|BeneFIX|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Pfizer Europe MA EEIG, |244.5||||H|||||0.48901|1849||
B02BD06|VON WILLEBRAND FACTOR AND COAG FACTORVIII IN COMB|BH127|Wilate 500|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Octapharma (IP) SPRL, |243.11||||H|||||0.48237|3418||
B02BD08|EPTACOG ALFA (ACTIVATED)|BH128|NovoSeven|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|2 mg (100 KIU)|MG|1|2|Novo Nordisk A.S., |1048.44||||H|||||527.35872|15557||
B02BD08|EPTACOG ALFA (ACTIVATED)|BH129|NovoSeven|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|5 mg (250 KIU)|MG|1|5|Novo Nordisk A.S., |2621.1||||H|||||527.35872|15558||
B02BD02|COAGULATION FACTOR VIII|BH130|Jivi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Bayer AG, |301.02||||H|||||0.60204|16728||
B02BD02|COAGULATION FACTOR VIII|BH131|Jivi|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000 IU|IU|1|1000|Bayer AG, |602.04||||H|||||0.60204|16729||
B02BD04|COAGULATION FACTOR IX|BH132|Refixia|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Novo Nordisk A/S, |515.11||||H|||||1.03367|17127||
B02BD02|COAGULATION FACTOR VIII|BH133|Esperoct|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Novo Nordisk A/S, |301.02||||H|||||0.60204|17167||
B02BB01|HUMAN FIBRINOGEN|BH135|Fibryga|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION/INFUSION|1000 mg|mg|1|1000|Octapharma (IP) SPRL, |423.43||||H|||||0.4232|17263||
B02BD02|COAGULATION FACTOR VIII|BH136|Afstyla|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|1000 IU|IU|1|1000|CSL Behring GmbH, |471.61||||H|||||0.52673|17416||
B02BD02|COAGULATION FACTOR VIII|BH137|Afstyla|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|250IU|IU|1|250|CSL Behring GmbH, |117.9||||H|||||0.52673|17415||
B02BD02|COAGULATION FACTOR VIII|BH138|Afstyla|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|CSL Behring GmbH, |235.81||||H|||||0.52673|17414||
B03XA06|Luspatercept|BH139|Reblozyl|POWDER FOR SOLUTION FOR INJECTION|25 mg|mg|1|25|Bristol-Myers Squibb Pharma EEIG, |1022.51|1|2|0|C|6|0||1|51.18837|53266|1|
B03XA06|Luspatercept|BH140|Reblozyl|POWDER FOR SOLUTION FOR INJECTION|75 mg|mg|1|75|Bristol-Myers Squibb Pharma EEIG, |3066.17|1|2|0|C|6|0||1|51.18837|53267|1|
B02BD02|COAGULATION FACTOR VIII|BH142|Kovaltry|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500IU|IU|1|500|Bayer AG, |235.81||||H|||||0.52673|50209||
B02BD02|COAGULATION FACTOR VIII|BH143|Kovaltry|POWDER AND SOLVENT FOR SOLUTION FOR INFUSION|1000 IU|IU|1|1000|Bayer AG, |471.61||||H|||||0.52673|50210||
B02BD01|COAGULATION FACTOR IX, II, VII AND X IN COMB.|BH144|Prothromplex Total|POWDER AND SOLVENT FOR SOLUTION FOR INJECTION|500 IU|IU|1|500|Baxalta Innovations GmbH, |173.19||||H|||||0.34638|62483||
B02BD03|FACTOR VIII INHIBITOR BYPASSING ACTIVITY|BH145|Feiba|POWDER AND SOLVENT FOR SOLUTION FOR INFUSION|100 U/ml (500 U)|U|1|500|Baxalta Innovations GmbH, |370.94|||0|H|||||0.74189|64522||
B02BD10|VON WILLEBRAND FACTOR (VONICOG ALFA)|BH146|Veyvondi|POWDER+SOLV. FOR SOL. FOR INJ.|650 IU|IU|1|650|Baxalta Innovations GmbH, |736.47||||H||||||55312||
B02BD10|VON WILLEBRAND FACTOR (VONICOG ALFA)|BH147|Veyvondi|POWDER+SOLV. FOR SOL. FOR INJ.|1300 IU|IU|1|1300|Baxalta Innovations GmbH, |1472.94||||H||||||55313||
H02AB02|Dexamethasone|HH005|Dexamethasone Sopharma|SOLUTION FOR INJECTION|4 mg/ml - 1 ml|mg|10|40| , |4.01|1|0|0|C|2|7||0|0.10031|42|1|
H02AB02|Dexamethasone|HH006|Dexamethasone KRKA|SOLUTION FOR INJECTION|4 mg/ml - 1 ml|mg|25|100|KRKA d.d., |10.03|1|0|0|C|2|7||0|0.10031|1195|1|
H01CB02|OCTREOTIDE|HH007|Sandostatin LAR|POWD.AND SOLVENT FOR SUSP. INJ.|20 mg|mg|1|20|Novartis Europharm Ltd., |189.91|2|1|0|C|7|2||0|9.77834|2230|1|
H01CB02|OCTREOTIDE|HH008|Sandostatin LAR|POWD.AND SOLVENT FOR SUSP. INJ.|30 mg|mg|1|30|Novartis Europharm Ltd., |284.9|2|1|0|C|7|2||0|9.77834|3243|1|
H02AB02|Dexamethasone|HH018|Dexason|SOL.FOR INJ|4 mg/ml - 1 ml|mg|25|100|Galenika International Kft., |10.03|1|0|0|C|2|7||0|0.10031|17512|1|
J06BA02|IMMUNOGLOBULIN HUMAN NORMAL, INTRAVASCULAR|JH012|IMMUNOVENIN-INTACT 5% IgG|SOL. FOR INF.|50 mg/ml -5 ml|mg|10|2500| - , |184.04|1|4|0|C|1|||1|0.07361|1318|0|
L01DB03|EPIRUBICIN|LH004|Farmorubicin PFS|SOL.FOR INJ|50 mg|mg|1|50|Pfizer Europe MA EEIG, |22.15|1|4|0|C||1||1|0.44287|2322|1|
L01BC01|CYTARABINE|LH005|Alexan|SOL.FOR INJ|50 mg/ml - 20 ml|mg|1|1000|Ebewe Pharma GmbH. N.fg. KG, |15.04|1|4|0|C||1||1|0.01503|866|1|
L01DB03|EPIRUBICIN|LH015|EPIRUBICIN EBEWE|CONCENTRATE FOR SOL. FOR INJECTION/INFUSION|2 mg/ml - 25 ml|mg|1|50|Ebewe Pharma GmbH. N.fg. KG, |22.15|1|4|0|C||1||1|0.44287|3280|1|
L01DB03|EPIRUBICIN|LH024|EPISINDAN|SOL. FOR INF.|2 mg/ml - 50 ml|mg|1|100|  , |44.3|1|4|0|C||1||1|0.44287|1221|1|
L01CD01|PACLITAXEL|LH030|Paclitaxel "Ebewe"|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 16.7 ml|mg|1|100.2|Ebewe Pharma GmbH. N.fg. KG, |14.41|1|4|0|C||1||1|0.11236|1831|1|
L01CD01|PACLITAXEL|LH046|Paclitaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 50 ml|mg|1|300|Accord Healthcare Polska , |43.23|1|4|0|C||1||1|0.11236|2868|1|
L01DB06|Idarubicin|LH047|ZAVEDOS|powder for sol. for inf.|5 mg|mg|1|5|Pfizer Enterprises S.A.R.L., |27.54|1|4|0|C||1||1|5.46596|3287|1|
L01DB06|Idarubicin|LH065|ZAVEDOS|powder for sol. for inf.|10 mg|mg|1|10|Pfizer Enterprises S.A.R.L., |55.08|1|4|0|C||1||1|5.46596|3288|1|
L01DB07|Mitoxantrone|LH075|MITOXANTRON EBEWE|concentrate for solution for infusion|2 mg/ml - 10 ml|mg|1|20|Ebewe Pharma GmbH. N.fg. KG, |35.08|1|4|0|C|7|1||1|1.75353|2338|1|
L01CA04|VINORELBINE|LH078|Vinorelbin Ebewe|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml - 5 ml|mg|1|50|Ebewe Pharma GmbH. N.fg. KG, |50.47|1|4|0|C|8|1||1|1.00868|3561|1|
L01XA01|CISPLATIN|LH109|Cisplatin Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|1 mg/ml - 50 ml|mg|1|50|Accord Healthcare Polska , |9.96|1|4|0|C||1||1|0.1581|3729|1|
L01XA02|CARBOPLATIN|LH113|CARBOPLATIN "EBEWE"|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml - 15 ml|mg|1|150|Ebewe Pharma GmbH. N.fg. KG, |29.95|1|4|0|C||1||1|0.19961|868|1|
L03AA02|FILGRASTIM|LH123|Nivestim|SOL. FOR INJ/INF IN PRE-FILLED SYRINGE|30 MIU/0.5 ml|mcg|5|1500|Pfizer Europe MA EEIG, |39.9|3|1|0|C|7|5||0|0.03681|2918|0|
L03AA02|FILGRASTIM|LH128|Zarzio|SOL. FOR INJ/INF IN PRE-FILLED SYRINGE|30 MIU/0.5 ml|mcg|5|1500|Sandoz GmbH, |39.9|3|1|0|C|7|5||0|0.03681|2598|0|
L01EH01|LAPATINIB|LH137|Tyverb|FILM-COATED TABLET|250 mg|mg|140|35000|Novartis Europharm Ltd., |1228.26|4|0|0|C|3|3||0|0.03508|3392|1|
L01EA03|NILOTINIB|LH139|Tasigna|CAPSULE, HARD|200 mg|mg|28|5600|Novartis Europharm Ltd., |305.96|4|0|0|C|3|3||0|0.05461|1828|1|
L01EA03|NILOTINIB|LH140|Tasigna|CAPSULE, HARD|150 mg|mg|28|4200|Novartis Europharm Ltd., |229.55|4|0|0|C|3|3||0|0.05461|1827|1|
L01EG01|TEMSIROLIMUS|LH158|Torisel|CONCENTRATE AND SOLVENT FOR SOLUTION FOR INJ.|30 mg|mg|1|30|Pfizer Europe MA EEIG, |700.69|1|4|0|C||3||1|23.34847|3375|1|
L01FE01|CETUXIMAB|LH160|ERBITUX|SOLUTION FOR INFUSION|5 mg/ml - 20 ml|mg|1|100|Merck Europe B.V., |175.42|1|4|0|C|7|3||1|1.75371|3513|1|
L01FG01|BEVACIZUMAB|LH161|Avastin|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg|mg|1|100|Roche Registration GmbH, |79.93|1|4|0|C|8|3||1|1.20024|3221|1|
L01FG01|BEVACIZUMAB|LH163|Avastin|CONCENTRATE FOR SOLUTION FOR INFUSION|400 mg|mg|1|400|Roche Registration GmbH, |314.21|1|4|0|C|8|3||1|1.20024|3222|1|
L01FE02|PANITUMUMAB|LH165|Vectibix|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg|mg|1|100|Amgen Eurpe B.V., |332.99|1|4|0|C|8|3||1|3.32994|3297|1|
L01EX01|SUNITINIB|LH172|Sutent|CAPSULE, HARD|12,5 mg|mg|30|375|Pfizer Europe MA EEIG, |109.19|4|0|0|C|3|3||0|0.39881|3307|1|
L01CE01|TOPOTECAN|LH175|Hycamtin|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|4 mg|mg|1|4|Sandoz Pharmaceuticals d.d., |51.17|1|4|0|C||1||1|12.78965|2389|1|
L01EX01|SUNITINIB|LH176|Sutent|CAPSULE, HARD|25 mg|mg|30|750|Pfizer Europe MA EEIG, |218.38|4|0|0|C|3|3||0|0.39881|3308|1|
L01EX01|SUNITINIB|LH177|Sutent|CAPSULE, HARD|50 mg|mg|30|1500|Pfizer Europe MA EEIG, |436.76|4|0|0|C|3|3||0|0.39881|3309|1|
L01CE01|TOPOTECAN|LH184|Hycamtin|CAPSULE, HARD|1 mg|mg|10|10|Sandoz Pharmaceuticals d.d., |275.15|4|0|0|C|3|1||0|27.51517|3314|1|
L01BA01|METHOTREXATE|LH187|Methotrexate Ebewe|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/ml - 10 ml|mg|1|1000|Ebewe Pharma GmbH. N.fg. KG, |16.87|1|4|0|C||1||1|0.01683|2714|1|
L01XX23|MITOTANE|LH202|Lysodren|TABLET|500 mg|mg|100|50000|Esteve Pharmaceuticals S.A., |595.58|4|0|0|C|3|1||0|0.01191|3202|1|
L01BB05|FLUDARABINE|LH219|Fludarabine Actavis|POWD.FOR SOL. FOR INJ/INF|50 mg|mg|1|50|  , |33.01|1|4|0|C||1||1|0.65895|1114|1|
L01XA03|OXALIPLATIN|LH227|Oxaliplatin-Tchaikapharma|POWDER FOR SOLUTION FOR INFUSION|100 mg|mg|1|100| -   , |15.26|1|3|0|C||1||1|0.1556|1419|1|
L01CD02|DOCETAXEL|LH230|Docetaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|80 mg/ 4 ml|mg|1|80|Accord Healthcare S.L.U., |16.85|1|2|0|C||1||1|0.21237|3890|1|
L01CE01|TOPOTECAN|LH233|Topotecan Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|1mg/ml - 4 ml|mg|1|4|Accord Healthcare Polska , |51.17|1|4|0|C||1||1|12.78965|2867|1|
L03AA13|PEGFILGRASTIM|LH234|Neulasta|SOLUTION FOR INJECTION|6 mg|mg|1|6|Amgen Europe B.V., |286.63|3|1|0|C|7|5||0|47.74952|3475|0|
L01XA03|OXALIPLATIN|LH237|OXALIPLATIN ACCORD|CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg/ml - 20 ml|mg|1|100|Accord Healthcare Polska , |15.26|1|3|0|C||1||1|0.1556|1487|1|
L04AD01|CICLOSPORIN|LH243|SANDIMMUN NEORAL|CAPS. SOFT|25 mg|mg|50|1250|Novartis Europharm Ltd., |15.42|4|0|0|C|3|||0|0.01233|1561|0|
L04AD01|CICLOSPORIN|LH244|SANDIMMUN NEORAL|CAPS. SOFT|50 mg|mg|50|2500|Novartis Europharm Ltd., |30.84|4|0|0|C|3|||0|0.01233|3535|0|
L04AD01|CICLOSPORIN|LH253|SANDIMMUN NEORAL|ORAL SOLUTION|5000mg|mg|1|5000|Novartis Europharm Ltd., |69.89|4|0|0|C|3|||0|0.01398|3937|0|
L01BC05|GEMCITABINE|LH260|GEMCITABINE ACCORD|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Polska , |18.37|1|4|0|C|8|1||1|0.01835|2428|1|
L01CD04|CABAZITAXEL|LH274|Jevtana|CONCENTRATE FOR SOLUTION FOR INFUSION|60 mg|mg|1|60|Sanofi Winthrop Industrie, |723.47|1|2|0|C|7|1||1|12.05177|3727|1|
L01DB01|DOXORUBICIN|LH275|Doxorubicin Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|2 mg/ml - 25 ml|mg|1|50|Accord Healthcare Polska , |8.52|1|3|0|C|7|1||1|0.16924|1325|1|
L01DB01|DOXORUBICIN|LH281|Myocet liposomal|POWDER, DISPERSION AND CONCENTRATE FOR DISPERSION FOR INFUSION|50 mg|mg|2|100|Cheplapharm Arzneimittel GmbH|575.66|1|2|0|C|7|1||1|5.7554|3463|1|
L01BC01|CYTARABINE|LH288|Cytarabine Accord|SOL. FOR INJ/INF|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Polska , |14.98|1|4|0|C||1||1|0.01497|3910|1|
L01BC06|CAPECITABINE|LH291|Capecitabine Accord|TABL. FILM. COAT.|500 mg|mg|120|60000|Accord Healthcare S.L.U., |57.28|4|0|0|C|3|1||0|0.00096|2314|1|
L01FX04|IPILIMUMAB|LH304|Yervoy|CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg/ml - 10 ml|mg|1|50|Bristol-Myers Squibb Pharma EEIG, |3244.01|1|4|0|C||4||1|64.86574|2253|1|
L01EC01|VEMURAFENIB|LH305|ZELBORAF|TABL. FILM. COAT.|240 mg|mg|56|13440|Roche Registration GmbH, |1279.64|4|0|0|C|3|3||0|0.09521|3683|1|
L01XX41|ERIBULIN|LH306|Halaven|SOL.FOR INJ|0.44mg/ml - 1 vial x 2ml|mg|1|0.88|Eisai GmbH, |131.64|1|4|0|C||1||1|149.48954|2995|1|
L01FD01|TRASTUZUMAB|LH310|Herceptin|SOL.FOR INJ|600 mg/5 ml|mg|1|600|Roche Registration GmbH, |1054.62|3|1|0|C|8|3||0|1.75732|3379|1|
L01CD01|PACLITAXEL|LH317|Paclitaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 16.7 ml|mg|1|100.2|Accord Healthcare Polska , |14.41|1|4|0|C||1||1|0.11236|3067|1|
L01FA01|RITUXIMAB|LH320|MabThera|SOL.FOR INJ|1400mg/15ml|mg|1|1400|Roche Registration GmbH, |1498.95|3|1|0|C||3||0|1.07068|3835|1|
L01XX35|ANAGRELIDE|LH321|THROMBOREDUCTIN|CAPSULE, HARD|0.5 mg|mg|100|50|AOP Orphan Pharmaceuticals GmbH, |116.94|4|0|0|C|3|||0|2.33875|808|1|
L01DB03|EPIRUBICIN|LH332|Episindan|SOLUTION FOR INFUSION|2 mg/ml - 25 ml|mg|1|50|  , |22.15|1|4|0|C||1||1|0.44287|3281|1|
L01FX05|BRENTUXIMAB VEDOTIN|LH334|ADCETRIS|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|50 mg|mg|1|50|Takeda Pharma A/S, |2991.26|1|3|0|C||3||1|60.65693|3425|1|
L01FD02|PERTUZUMAB|LH335|PERJETA|CONCENTRATE FOR SOLUTION FOR INFUSION|420 MG|mg|1|420|Roche Registration GmbH, |2287.06|1|2|0|C|8|3||0|5.44416|4002|1|
L01EB03|AFATINIB|LH336|GIOTRIF|FILM-COATED TABLET|30 mg|mg|28|840|Boehringer Ingelheim International GmbH, |1223.94|4|0|0|C|3|3||0|1.49022|3174|1|
L01EB03|AFATINIB|LH337|GIOTRIF|FILM-COATED TABLET|40 mg|mg|28|1120|Boehringer Ingelheim International GmbH, |1631.92|4|0|0|C|3|3||0|1.49022|3175|1|
L01ED01|CRIZOTINIB|LH338|XALKORI|CAPSULE, HARD|250 mg|mg|60|15000|Pfizer Europe MA EEIG, |4095.08|4|0|0|C|3|3||0|0.27294|3273|1|
L01EK01|AXITINIB|LH339|Inlyta|FILM-COATED TABLET|5 mg|mg|56|280|Pfizer Europe MA EEIG, |1214.99|4|0|0|C|3|3||0|9.78993|3263|1|
L01EJ01|RUXOLITINIB|LH340|JAKAVI|TABL|5 mg|mg|56|280|Novartis Europharm Ltd., |1520.29|4|0|0|C|3|3||0|5.4606|3415|1|
L01XX44|AFLIBERCEPT|LH341|ZALTRAP|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 8ml|mg|1|200|Sanofi Winthrop Industrie, |581.03|1|3|0|C|8|3||1|2.90417|3319|1|
L01XX44|AFLIBERCEPT|LH342|ZALTRAP|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Sanofi Winthrop Industrie, |290.52|1|3|0|C|8|3||1|2.90417|3320|1|
L03AA14|LIPEGFILGRASTIM|LH344|LONQUEX|SOL. INJ. PRE-FILLED SYRINGE|6mg/0.6ml|mg|1|6|Teva B.V, |472.31|3|1|0|C|7|5||0|79.43626|2930|0|
L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH348|Bendamustine Actavis|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|100 mg|mg|1|100|Teva B.V, |39.63|1|4|0|C|6|1||1|0.41649|4013|1|
L01XG01|BORTEZOMIB|LH349|Vortemyel|POWDER FOR SOLUTION FOR INJECTION|3.5 mg|mg|1|3.5|Zentiva k.s.,  |76.69|1|4|0|C||3||1|21.9076|4014|1|
L01XG01|BORTEZOMIB|LH354|Bortezomib Actavis|POWD.INJ|3.5 mg|mg|1|3.5|Teva B.V, |76.69|1|4|0|C||3||1|21.9076|4075|1|
L01FD03|TRASTUZUMAB EMTANSINE|LH358|Kadcyla|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/5 ml|mg|1|100|Roche Registration GmbH, |1570.19|1|2|0|C||3||1|15.74661|4095|1|
L01FD03|TRASTUZUMAB EMTANSINE|LH359|Kadcyla|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|160 mg/ 8 ml|mg|1|160|Roche Registration GmbH, |2512.3|1|2|0|C||3||1|15.74661|4096|1|
L01EX04|VANDETANIB|LH360|Caprelsa|FILM-COATED TABLET|100 mg|mg|30|3000|Sanofi B.V., |1173.81|4|0|0|C|3|3||0|0.39541|4051|1|
L01EX04|VANDETANIB|LH361|Caprelsa|FILM-COATED TABLET|300 mg|mg|30|9000|Sanofi B.V., |3521.45|4|0|0|C|3|3||0|0.39541|4052|1|
L01EA04|BOSUTINIB|LH362|Bosulif|FILM-COATED TABLET|100 mg|mg|28|2800|Pfizer Europe MA EEIG, |237.94|4|0|0|C|3|3||0|0.08498|4036|1|
L01EA04|BOSUTINIB|LH363|Bosulif|FILM-COATED TABLET|500 mg|mg|28|14000|Pfizer Europe MA EEIG, |1189.7|4|0|0|C|3|3||0|0.08498|4037|1|
L01EC02|DABRAFENIB|LH364|Tafinlar|CAPSULE, HARD|75 mg|mg|120|9000|Novartis Europharm Ltd., |4977.62|4|0|0|C|3|3||0|0.57219|3563|1|
L01XJ01|VISMODEGIB|LH365|Erivedge|CAPSULE, HARD|150 mg|mg|28|4200|Roche Registration GmbH, |3837.53|4|0|0|C|3|3||0|0.94694|4035|1|
L01AA02|CHLORAMBUCIL|LH366|Leukeran|TABL. FILM. COAT.|2 mg|mg|25|50|Aspen Pharma Trading Ltd., |12.7|4|0|0|C|3|1||0|0.25391|4160|1|
L01BB02|MERCAPTOPURINE|LH368|Puri-Nethol|TABL|50 mg|mg|25|1250|Aspen Pharma Trading Ltd., |10.6|4|0|0|C|3|1||0|0.00848|4159|1|
L01FG02|RAMUCIRUMAB|LH370|Cyramza|CONCENTRATE FOR SOLUTION FOR INFUSION|10 MG/ML - 10 ML|mg|2|200|Eli Lilly Nederland B.V., |822.13|1|3|0|C||3||1|4.10895|4158|1|
L01BA04|PEMETREXED|LH375|Armisarte|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 20 ml|mg|1|500|Actavis Group PTC ehf., |268.8|1|2|0|C|7|1||1|0.77921|4220|1|
L01BA04|PEMETREXED|LH376|Armisarte|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 40 ml|mg|1|1000|Actavis Group PTC ehf., |537.6|1|2|0|C|7|1||1|0.77921|4221|1|
L01AX03|TEMOZOLOMIDE|LH379|Temozolomide Accord|CAPSULE, HARD|100 mg|mg|5|500|Accord Healthcare S.L.U., |31.62|4|0|0|C|3|1||0|0.06314|4195|1|
L01BC02|FLUOROURACIL|LH382|5-Fluorouracil Ebewe|CONCENTRATE FOR SOL. FOR INJECTION/INFUSION|50 mg/ml - 20 ml|mg|10|10000|Ebewe Pharma GmbH. N.fg. KG, |47.42|1|4|0|C|8|1||1|0.00418|15089|1|
L03AX03|Mycobacterium bovis BCG|LH386|CALGEVAX|Powder for suspension|11.25|mg|4|45| - , |106.3|1|4|0|C|6|4||0|2.36152|4210|1|
L01EL01|IBRUTINIB|LH390|Imbruvica|CAPSULE, HARD|140|mg|90|12600|Janssen-Cilag International N.V., |5738.65|4|0|0|C|3|3||0|0.45545|15533|1|
L01EK01|AXITINIB|LH393|Inlyta|TABL. FILM. COAT.|1 mg|mg|56|56|Pfizer Europe MA EEIG, |243|4|0|0|C|3|3||0|9.78993|15567|1|
L01FF02|EMBROLIZUMAB|LH399|Keytruda|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Merck Sharp & Dohme B.V., |2636.51|1|2|0|C||4||0|28.79324|15839|1|
L01EA01|IMATINIB|LH402|Imatinib Teva Pharma|TABL. FILM. COAT.|100 mg|mg|120|12000|Teva B.V, |81.96|4|0|0|C|3|3||0|0.00675|15855|1|
L01EB02|ERLOTINIB|LH404|Erlotinib Sandoz|TABL. FILM. COAT.|100 mg|mg|30|3000|Sandoz d.d., |276.89|4|0|0|C|3|3||0|0.09228|15910|1|
L01EB02|ERLOTINIB|LH405|Erlotinib Actavis|FILM-COATED TABLET|100 mg|mg|30|3000|Teva B.V, |276.89|4|0|0|C|3|3||0|0.09228|15917|1|
L01EB02|ERLOTINIB|LH406|Erlotinib Actavis|FILM-COATED TABLET|150 mg|mg|30|4500|Teva B.V, |415.33|4|0|0|C|3|3||0|0.09228|15918|1|
L01FA03|OBINUTUZUMAB|LH409|Gazyvaro|CONCENTRATE FOR SOLUTION FOR INFUSION|1000 mg - 40 ml|mg|1|1000|Roche Registration GmbH, |2543.39|1|4|0|C||3||1|2.54339|9051|1|
L01FF01|NIVOLUMAB|LH410|Opdivo|CONCENTRATE FOR SOLUTION FOR INFUSION|10 MG/ML - 10 ML|mg|1|100|Bristol-Myers Squibb Pharma EEIG, |1162.23|1|2|0|C||4||1|11.6197|15972|1|
L01FF01|NIVOLUMAB|LH411|Opdivo|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml-4ml|mg|1|40|Bristol-Myers Squibb Pharma EEIG, |464.89|1|2|0|C||4||1|11.6197|15971|1|
L01FX07|BLINATUMOMAB|LH412|Blincyto|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|38.5mg|mcg|1|38.5|Amgen Eurpe B.V., |2428.9|1|2|0|C||3||1|63.4557|15954|1|
L01EX05|REGORAFENIB|LH414|Stivarga|FILM-COATED TABLET|40 mg|mg|84|3360|Bayer AG, |2290.72|4|0|0|C|3|3||0|0.68144|8906|1|
L01EA05|PONATINIB|LH415|Iclusig|FILM-COATED TABLET|15 mg|mg|60|900|Incyte Biosciences Distribution B.V., |5541.16|4|0|0|C|3|3||0|6.2769|15297|1|
L01EF01|PALBOCICLIB|LH416|Ibrance|CAPSULE, HARD|75 mg|mg|21|1575|Pfizer Europe MA EEIG, |1077.41|4|0|0|C|3|3||0|0.71974|15722|1|
L01EF01|PALBOCICLIB|LH417|Ibrance|CAPSULE, HARD|100 mg|mg|21|2100|Pfizer Europe MA EEIG, |1436.55|4|0|0|C|3|3||0|0.71974|15724|1|
L01EF01|PALBOCICLIB|LH418|Ibrance|CAPSULE, HARD|125 mg|mg|21|2625|Pfizer Europe MA EEIG, |1795.69|4|0|0|C|3|3||0|0.71974|15723|1|
L01EB04|OSIMERTINIB|LH419|Tagrisso|FILM-COATED TABLET|40 mg|mg|28|1120|Astra Zeneca AB, |2814.11|4|0|0|C|3|3||0|2.51225|15969|1|
L01EB04|OSIMERTINIB|LH420|Tagrisso|FILM-COATED TABLET|80 mg|mg|28|2240|Astra Zeneca AB, |5628.22|4|0|0|C|3|3||0|2.51225|15785|1|
L01XG02|CARFILZOMIB|LH421|Kyprolis|POWDER FOR SOLUTION FOR INFUSION|60 mg|mg|1|60|Amgen Eurpe B.V., |1063.61|1|4|0|C||3||1|17.72688|15897|1|
L01XX52|venetoclax|LH426|Venclyxto|Film coated tablet|100|mg|112|11200|AbbVie Deutchland GmbH & Co. KG, |5035.16|4|0|0|C|3|3||0|0.45273|15958|1|
L01EB02|ERLOTINIB|LH427|Erlotinib Sandoz|TABL. FILM. COAT.|150 mg|mg|30|4500|Sandoz d.d., |415.33|4|0|0|C|3|3||0|0.09228|15938|1|
L01AA01|Cyclophosphamide|LH430|Endoxan|Powder for solution for injection|500|mg|1|500|  , |10.38|1|4|0|C|7|1||1|0.01779|15853|1|
L01XG01|BORTEZOMIB|LH432|Bortezocon|POWDER FOR SOLUTION FOR INJECTION|3.5 mg|mg|1|3.5| , |76.69|1|4|0|C||3||1|21.9076|15990|1|
L01AA06|Ifosfamide|LH433|Holoxan|Powder for solution for infusion|2000|mg|1|2000|  , |113.45|1|4|0|C||1||1|0.0547|15975|1|
L01XA03|OXALIPLATIN|LH435|Oxaliplatin Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg/ml - 20 ml|mg|1|100|  , |15.26|1|3|0|C||1||1|0.1556|16038|1|
L01FA01|RITUXIMAB|LH436|Truxima|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg|mg|2|200|Celltrion Healthcare Hungary Kft., |125.03|1|4|0|C||3||1|0.62502|15909|1|
L01FA01|RITUXIMAB|LH437|Truxima|CONCENTRATE FOR SOLUTION FOR INFUSION|500 mg|mg|1|500|Celltrion Healthcare Hungary Kft., |312.58|1|4|0|C||3||1|0.62502|15911|1|
L03AA02|FILGRASTIM|LH442|Accofil|CONCENTRATE FOR SOL. FOR INJECTION/INFUSION|30 MU (300 mcg/0.5 ml)|mcg|5|1500|Accord Healthcare S.L.U., |39.9|3|1|0|C|7|5||0|0.03681|16007|0|
L01BA01|METHOTREXATE|LH443|Methotrexate Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/ml - 10 ml|mg|1|1000|Accord Healthcare Polska , |16.87|1|4|0|C||1||1|0.01683|15946|1|
L01CE02|IRINOTECAN|LH446|Irinotecan Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Accord Healthcare Polska , |12.72|1|3|0|C||1||1|0.12718|16166|1|
L02BX03|ABIRATERONE ACETATE|LH447|Zytiga|TABLETS FILM COATED|500 mg|mg|60|30000|Janssen-Cilag International N.V., |277.93|4|0|0|C|3|2||0|0.00926|16148|1|
L01CB01|ETOPOSIDE|LH450|Etoposide Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Accord Healthcare Polska , |6.12|1|4|0|C||1||1|0.06105|16266|1|
L01FA01|RITUXIMAB|LH454|Rixathon|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg/10 ml|mg|2|200|Sandoz GmbH, |125.03|1|4|0|C||3||1|0.62502|16316|1|
L01FA01|RITUXIMAB|LH455|Rixathon|CONCENTRATE FOR SOLUTION FOR INFUSION|500 mg/50 ml|mg|1|500|Sandoz GmbH, |312.58|1|4|0|C||3||1|0.62502|16315|1|
L01CD01|PACLITAXEL|LH456|Paclitaxel Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|6 mg/ml - 50 ml|mg|1|300|  , |43.23|1|4|0|C||1||1|0.11236|16346|1|
L01XG01|BORTEZOMIB|LH457|Bortezomib Sandoz|POWDER FOR SOLUTION FOR INJECTION|3.5 mg|mg|1|3.5|Sandoz d.d., |76.69|1|4|0|C||3||1|21.9076|16347|1|
L01FA01|RITUXIMAB|LH458|MabThera|SOLUTION FOR INJECTION|1600 mg/13.4 ml|mg|1|1600|Roche Registration GmbH, |1713.08|3|1|0|C||3||0|1.07068|16352|1|
L01BC59|TRIFLURIDINE/TIPIRACIL|LH459|Lonsurf|TABL. FILM. COAT.|15mg/6.14mg|MG|20|300|Les Laboratoires Servier, |456.98|4|0|0|C|3|1||0|27.1396|15584|1|
L01CD02|DOCETAXEL|LH460|Docetaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|160 mg/ 8 ml|mg|1|160|Accord Healthcare S.L.U., |33.7|1|2|0|C||1||1|0.21237|2865|1|
L01BC59|TRIFLURIDINE/TIPIRACIL|LH461|Lonsurf|TABL. FILM. COAT.|20mg/8.19mg|MG|20|400|Les Laboratoires Servier, |607.26|4|0|0|C|3|1||0|36.08359|15583|1|
L01XA03|OXALIPLATIN|LH463|Oxaliplatin Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|5 MG/ML - 40 ML|mg|1|200|  , |30.52|1|3|0|C||1||1|0.1556|16372|1|
L01FC01|DARATUMUMAB|LH464|DARZALEX|CONCENTRATE FOR SOLUTION FOR INFUSION|20 MG/ ML - 20ML|mg|1|400|Janssen-Cilag International N.V., |1644.95|1|4|0|C||4||1|4.13712|16383|1|
L01ED03|ALECTINIB|LH465|Alecensa|CAPSULE, HARD|150 mg|mg|224|33600|Roche Registration GmbH, |4359.18|4|0|0|C|3|3||0|0.14413|15874|1|
L01XG03|IXAZOMIB|LH466|Ninlaro|CAPSULE, HARD|2.3 mg|mg|3|6.9|Takeda Pharma A/S, |2321.92|4|0|0|C|3|3||0|336.34318|16389|1|
L01XG03|IXAZOMIB|LH467|Ninlaro|CAPSULE, HARD|3 mg|mg|3|9|Takeda Pharma A/S, |3028.6|4|0|0|C|3|3||0|336.34318|16390|1|
L01XG03|IXAZOMIB|LH468|Ninlaro|CAPSULE, HARD|4 mg|mg|3|12|Takeda Pharma A/S, |4038.13|4|0|0|C|3|3||0|336.34318|16391|1|
L01FB01|INOTUZUMAB OZOGAMICIN|LH469|BESPONSA|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|1 mg|mg|1|1|Pfizer Europe MA EEIG, |8420.53|1|4|0|C||4||1|9364.03244|16071|1|
L01FF05|ATEZOLIZUMAB|LH470|Tecentriq|CONCENTRATE FOR SOLUTION FOR INFUSION|1200 mg - 20 ml|mg|1|1200|Roche Registration GmbH, |3705.46|1|2|0|C||4||0|3.19204|16088|1|
L01EG02|EVEROLIMUS|LH471|Everolimus Viatris|TABLET|5 mg|mg|30|150|Viatris Limited, |346.86|4|0|0|C|3|3||0|2.31002|16405|1|
L01EG02|EVEROLIMUS|LH472|Everolimus Viatris|TABLET|10 mg|mg|30|300|Viatris Limited, |693.72|4|0|0|C|3|3||0|2.31002|16406|1|
L01EG02|EVEROLIMUS|LH473|Everolimus Teva|TABLET|10 mg|mg|30|300|Teva B.V, |693.72|4|0|0|C|3|3||0|2.31002|16132|1|
L01FD01|TRASTUZUMAB|LH474|Trazimera|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|150 mg|MG|1|150|Pfizer Europe MA EEIG, |138.92|1|4|0|C||3||1|1.27181|16472|1|
L03AA13|PEGFILGRASTIM|LH476|Pelgraz|SOLUTION FOR INJECTION|10mg/ml-0.6 ml|mg|1|6|Accord Healthcare S.L.U., |286.63|3|1|0|C|7|5||0|47.74952|16452|0|
L03AA13|PEGFILGRASTIM|LH477|Ziextenzo|SOLUTION FOR INJECTION|10mg/ml-0.6 ml|mg|1|6|Sandoz GmbH, |286.63|3|1|0|C|7|5||0|47.74952|16451|0|
L01FD01|TRASTUZUMAB|LH478|Ogivri|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|150 mg|mg|1|150|Biosimilar Collaborations Ireland Limited, |138.92|1|4|0|C||3||1|1.27181|16471|1|
L01XG02|CARFILZOMIB|LH479|Kyprolis|POWDER FOR SOLUTION FOR INFISION|10 mg|mg|1|10|Amgen Eurpe B.V., |177.27|1|4|0|C||3||1|17.72688|16496|1|
L01XG02|CARFILZOMIB|LH480|Kyprolis|POWDER FOR SOLUTION FOR INFISION|30 mg|mg|1|30|Amgen Eurpe B.V., |531.8|1|4|0|C||3||1|17.72688|16497|1|
L01CE02|IRINOTECAN|LH483|Irinotecan Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|MG|1|100|  , |12.72|1|3|0|C||1||1|0.12718|16545|1|
L01XK01|OLAPARIB|LH484|Lynparza|TABL. FILM. COAT.|150 mg|MG|56|8400|Astra Zeneca AB, |2419.78|4|0|0|C|3|3||0|0.29814|16571|1|
L01XK01|OLAPARIB|LH485|Lynparza|TABL. FILM. COAT.|100 mg|MG|56|5600|Astra Zeneca AB, |1612.61|4|0|0|C|3|3||0|0.29814|16570|1|
L01FC01|DARATUMUMAB|LH490|DARZALEX|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Janssen-Cilag International N.V., |411.24|1|4|0|C||4||1|4.13712|16382|1|
L01FX02|GEMTUZUMAB OZOGAMICIN|LH491|Mylotarg|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg|mg|1|5|Pfizer Europe MA EEIG, |7028.95|1|4|0|C|7|4||1|1405.47314|16703|1|
L01FF03|DURVALUMAB|LH492|Imfinzi|CONCENTRATE FOR SOLUTION FOR INFUSION|50 mg/ml - 10 ml|mg|1|500|Astra Zeneca AB, |2071.63|1|3|0|C||3||1|4.36129|16712|1|
L01FF03|DURVALUMAB|LH493|Imfinzi|CONCENTRATE FOR SOLUTION FOR INFUSION|50 mg/ml - 2.4 ml|mg|1|120|Astra Zeneca AB, |497.19|1|3|0|C||3||1|4.36129|16711|1|
L01EE01|TRAMETINIB|LH494|Mekinist|FILM-COATED TABLET|2 mg|mg|30|60|Novartis Europharm Ltd., |3822.67|4|0|0|C|3|3||0|64.96178|15093|1|
L01EX10|MIDOSTAURIN|LH495|Rydapt|CAPS. SOFT|25 mg|mg|112|2800|Novartis Europharm Ltd., |12426.1|4|0|0|C|3|3||0|4.43691|16111|1|
L01EF02|RIBOCICLIB|LH497|Kisqali|FILM-COATED TABLET|200 mg|mg|21|4200|Novartis Europharm Ltd., |822.66|4|0|0|C|3|3||0|0.20151|16147|1|
L01EE02|COBIMETINIB|LH498|Cotellic|TABL. FILM. COAT.|20 mg|mg|63|1260|Roche Registration GmbH, |5206.94|4|0|0|C|3|3||0|4.18632|15005|1|
L01CD02|DOCETAXEL|LH501|Docetaxel Novamed|CONCENTRATE FOR SOLUTION FOR INFUSION|20mg/ml-8ml|mg|1|160|  , |33.7|1|2|0|C||1||1|0.21237|16740|1|
L01CD02|DOCETAXEL|LH502|Docetaxel Novamed|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 4 ml|mg|1|80|  , |16.85|1|2|0|C||1||1|0.21237|16741|1|
L01CE02|IRINOTECAN|LH503|IRINOTECAN NOVAMED|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|  , |12.72|1|3|0|C||1||1|0.12718|16106|1|
L01FF04|AVELUMAB|LH504|Bavencio|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 10 ml|mg|1|200|Merck Europe B.V., |777.19|1|3|0|C||4||1|3.93497|16743|1|
L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH505|Bendamustine Sandoz|POWDER FOR CONCENTRATE SOLUTION FOR INFUSION|100 mg|mg|1|100|Sandoz d.d., |39.63|1|4|0|C|6|1||1|0.41649|16773|1|
L01EF03|ABEMACICLIB|LH506|Verzenios|TABL. FILM. COAT.|150 mg|mg|42|6300|Eli Lilly Nederland B.V., |1975.6|4|0|0|C|3|3||0|0.31352|16779|1|
L01EF03|ABEMACICLIB|LH507|Verzenios|TABL. FILM. COAT.|100 mg|mg|42|4200|Eli Lilly Nederland B.V., |1317.07|4|0|0|C|3|3||0|0.31352|16780|1|
L01EF03|ABEMACICLIB|LH508|Verzenios|TABL. FILM. COAT.|50 mg|mg|42|2100|Eli Lilly Nederland B.V., |658.53|4|0|0|C|3|3||0|0.31352|16781|1|
L01XF03|BEXAROTENE|LH509|Targretin|CAPSULE, SOFT|75 mg|mg|100|7500|H.A.C. Pharma, |488.81|4|0|0|C|3|3||0|0.12746|16778|1|
L01EX09|NINTEDANIB|LH510|Vargatef|CAPSULE, SOFT|150 mg|mg|60|9000|Boehringer Ingelheim International GmbH, |1825.36|4|0|0|C|3|1||0|0.20273|16730|1|
L01EX09|NINTEDANIB|LH511|Vargatef|CAPSULE, SOFT|100 mg|mg|120|12000|Boehringer Ingelheim International GmbH, |2434.33|4|0|0|C|3|1||0|0.20273|16731|1|
L01XX24|PEGASPARGASE|LH512|Oncaspar|POWD.FOR SOL. FOR INJ/INF|750 U/ml - 3750 U|IU|1|3750|Les Laboratoires Servier, |1759.44|1|3|0|C||1||1|0.46895|16704|1|
L01XE43|BRIGATINIB|LH517|Alunbrig|TABL. FILM. COAT.|30 mg|mg|28|840|Takeda Pharma A/S, |660.95|4|0|0|C|3|3||0|0.83973|16830|1|
L01XE43|BRIGATINIB|LH518|Alunbrig|TABL. FILM. COAT.|90 mg|mg|28|2520|Takeda Pharma A/S, |1982.84|4|0|0|C|3|3||0|0.83973|16832|1|
L01XE43|BRIGATINIB|LH519|Alunbrig|TABL. FILM. COAT.|180 mg|mg|28|5040|Takeda Pharma A/S, |3965.69|4|0|0|C|3|3||0|0.83973|16833|1|
L04AX06|POMALIDOMIDE|LH520|Imnovid|CAPSULE, HARD|4 mg|mg|21|84|Bristol-Myers Squibb Pharma EEIG, |1974.29|4|0|0|C|3|1||0|23.49191|16829|1|
L02BB04|ENZALUTAMIDE|LH522|Xtandi|TABL. FILM. COAT.|40 mg|mg|112|4480|Astellas Pharma Europe B.V., |2553.89|4|0|0|C|3|2||0|0.62971|16624|1|
L01FF05|ATEZOLIZUMAB|LH523|Tecentriq|CONCENTRATE FOR SOLUTION FOR INFUSION|840mg - 14ml|mg|1|840|Roche Registration GmbH, |2593.82|1|2|0|C||4||0|3.19204|16860|1|
L01CD01|PACLITAXEL|LH524|Pazenir|POWDER FOR DISPERSION FOR INFUSION|5mg/ml (100mg)|mg|1|100|Ratiopharm GmbH, |154.63|1|3|0|C||1||1|1.38164|16868|1|
L01XE43|BRIGATINIB|LH528|Alunbrig|TABL. FILM. COAT.|90 mg + 180 mg|mg|28|4410|Takeda Pharma A/S, |3469.96|4|0|0|C|3|3||0|0.83973|16976|1|
L01BC05|GEMCITABINE|LH529|Gemsol|CONCENTRATE FOR SOLUTION FOR INFUSION|40 mg/ml - 25 ml|MG|1|1000|Ebewe Pharma GmbH. N.fg. KG, |18.37|1|4|0|C|8|1||1|0.01835|16985|1|
L01CD02|DOCETAXEL|LH530|Docetaxel Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 4 ml|MG|1|80|  , |16.85|1|2|0|C||1||1|0.21237|17009|1|
L01CD02|DOCETAXEL|LH531|Docetaxel Bulgermed|CONCENTRATE FOR SOLUTION FOR INFUSION|20mg/ml-8ml|MG|1|160|  , |33.7|1|2|0|C||1||1|0.21237|17010|1|
L01BB07|NELARABINE|LH532|Atriance|SOLUTION FOR INFUSION|5 mg/ml - 50ml|mg|1|250|Sandoz Pharmaceuticals d.d., |288.9|1|4|0|C||1||1|1.13294|16987|1|
L01XA01|CISPLATIN|LH533|Cisplatin Ebewe|CONCENTRATE FOR SOLUTION FOR INFUSION|1 mg/ml - 50 ml|mg|1|50|Ebewe Pharma GmbH. N.fg. KG, |9.96|1|4|0|C||1||1|0.1581|17026|1|
L01XA03|OXALIPLATIN|LH534|Oxaliplatin Ebewe|CONCENTRATE FOR SOLUTION FOR INFUSION|5 mg/ml - 20 ml|mg|1|100|Ebewe Pharma GmbH. N.fg. KG, |15.26|1|3|0|C||1||1|0.1556|17039|1|
L01EX08|LENVATINIB|LH537|Lenvima|CAPSULE, HARD|4 mg|mg|30|120|Eisai GmbH, |1162.18|4|0|0|C|3|3||0|10.2565|17079|1|
L01FG01|BEVACIZUMAB|LH538|Zirabev|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|MG|1|400|Pfizer Europe MA EEIG, |314.21|1|4|0|C|8|3||1|1.20024|17139|1|
L01FG01|BEVACIZUMAB|LH539|Zirabev|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|MG|1|100|Pfizer Europe MA EEIG, |79.93|1|4|0|C|8|3||1|1.20024|17138|1|
L01CE02|IRINOTECAN|LH540|Onivyde pegylated liposomal|CONCENTRATE FOR DISPERSION FOR INFUSION|4.3 mg/ml - 10 ml|mg|1|43|Les Laboratoires Servier, |954.16|1|4|0|C|7|1||1|22.18536|16622|1|
L02BB05|APALUTAMIDE|LH541|Erleada|TABL. FILM. COAT.|60 mg|mg|120|7200|Janssen-Cilag International N.V., |2767.79|4|0|0|C|3|3||0|0.41426|17140|1|
L04AX04|LENALIDOMIDE|LH543|Lenalidomide Sandoz|CAPSULE, HARD|10 mg|mg|21|210|Sandoz d.d., |134.46|4|0|0|C|3|1||0|1.3142|17113|1|
L04AX04|LENALIDOMIDE|LH544|Lenalidomide Sandoz|CAPSULE, HARD|25 mg|mg|21|525|Sandoz d.d., |336.14|4|0|0|C|3|1||0|1.3142|17114|1|
L01FF06|CEMIPLIMAB|LH545|Libtayo|CONCENTRATE FOR SOLUTION FOR INFUSION|350 mg|mg|1|350|Regeneron Ireland Designated Activity Company (DAC), |3710.53|1|2|0|C||3||0|11.39097|17178|1|
L01EX13|GILTERITINIB|LH546|Xospata|TABL. FILM. COAT.|40 mg|mg|84|3360|Astellas Pharma Europe B.V., |17905.06|4|0|0|C|3|1||0|5.39033|17152|1|
L04AX04|LENALIDOMIDE|LH547|Lenalidomide Pharmascience|CAPSULE, HARD|25 mg|mg|21|525|Pharmascience International Ltd., |336.14|4|0|0|C|3|1||0|1.3142|17186|1|
L01BA04|PEMETREXED|LH548|Pemetrexed Sandoz|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 20 ml|mg|1|500|Sandoz d.d., |268.8|1|2|0|C|7|1||1|0.77921|17199|1|
L01BA04|PEMETREXED|LH549|Pemetrexed Sandoz|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 40 ml|mg|1|1000|Sandoz d.d., |537.6|1|2|0|C|7|1||1|0.77921|17200|1|
L04AX04|LENALIDOMIDE|LH550|Lenalidomide Pharmascience|CAPSULE, HARD|5 mg|mg|21|105|Pharmascience International Ltd., |67.23|4|0|0|C|3|1||0|1.3142|17223|1|
L04AX04|LENALIDOMIDE|LH551|Lenalidomide Pharmascience|CAPSULE, HARD|10 mg|mg|21|210|Pharmascience International Ltd., |134.46|4|0|0|C|3|1||0|1.3142|17224|1|
L01BC07|AZACITIDINE|LH552|Azacitidine Sandoz|POWD.SUSP|25mg/ml|mg|1|100|Sandoz d.d., |70.15|3|1|0|C||1||1|0.91087|17226|1|
L01BC07|AZACITIDINE|LH553|Azacitidine Pharmascience|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 150 mg)|mg|1|150|Pharmascience International Ltd., |105.23|3|1|0|C||1||1|0.91087|17305|1|
L01BC07|AZACITIDINE|LH554|Azacitidine Pharmascience|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 100 mg)|mg|1|100|Pharmascience International Ltd., |70.15|3|1|0|C||1||1|0.91087|17306|1|
L01EX02|SORAFENIB|LH555|Sorafenib Pharmascience|TABL. FILM. COAT.|200 mg|mg|112|22400|Pharmascience International Ltd., |708.42|4|0|0|C|3|3||0|0.0316|17302|1|
L01EX02|SORAFENIB|LH556|Nexavar|TABL. FILM. COAT.|200 mg|mg|112|22400|Bayer AG, |708.42|4|0|0|C|3|3||0|0.06045|3435|1|
L01ED05|LORLATINIB|LH558|Lorviqua|TABL. FILM. COAT.|100 mg|mg|30|3000|Pfizer Europe MA EEIG, |4229.38|4|0|0|C|3|3||0|1.44151|16795|1|
L01FG01|BEVACIZUMAB|LH559|Alymsys|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Mabxience Research SL, |79.93|1|3|0|C|8|3||1|1.20024|17390|1|
L01FG01|BEVACIZUMAB|LH560|Alymsys|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|mg|1|400|Mabxience Research SL, |314.21|1|3|0|C|8|3||1|1.20024|17389|1|
L01EX01|SUNITINIB|LH571|Suniticon|CAPSULE, HARD|50 mg|mg|30|1500| , |436.76|4|0|0|C|3|3||0|0.39881|17490|1|
L01EX01|SUNITINIB|LH572|Suniticon|CAPSULE, HARD|12.5 mg|mg|30|375| , |109.19|4|0|0|C|3|3||0|0.39881|17489|1|
L01EG02|EVEROLIMUS|LH576|Everolimus Sandoz|TABLET|10 mg|mg|30|300|Sandoz d.d., |693.72|4|0|0|C|3|3||0|2.31002|17521|1|
L01ED05|LORLATINIB|LH577|Lorviqua|TABL. FILM. COAT.|25 mg|mg|90|2250|Pfizer Europe MA EEIG, |3172.04|4|0|0|C|3|3||0|1.44151|17262|1|
L01EB01|GEFITINIB|LH578|Gefiticon|TABL. FILM. COAT.|250 mg|mg|30|7500| , |1233.23|4|0|0|C|3|3||0|0.01612|17511|1|
L02BB06|DAROLUTAMIDE|LH579|Nubeqa|FILM-COATED TABLET|300 mg|mg|112|33600|Bayer AG, |3283.49|4|0|0|C|3|3||0|0.0977|17538|1|
L01BC07|AZACITIDINE|LH580|Azacitidine Stada Arzneimittel|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 100 mg)|mg|1|100|Stada Arzneimittel AG, |70.15|3|1|0|C||1||1|0.91087|17397|1|
L01FG01|BEVACIZUMAB|LH581|Oyavas|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|mg|1|400|Stada Arzneimittel AG, |314.21|1|3|0|C|8|3||1|1.20024|17380|1|
L01FG01|BEVACIZUMAB|LH582|Oyavas|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Stada Arzneimittel AG, |79.93|1|3|0|C|8|3||1|1.20024|17379|1|
L01BC07|AZACITIDINE|LH583|Azacitidine Accord|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 100 mg)|mg|1|100|Accord Healthcare S.L.U., |70.15|3|1|0|C||1||1|0.91087|17566|1|
L01EC03|ENCORAFENIB|LH584|Braftovi|CAPSULE, HARD|75 mg|mg|42|3150|Pierre Fabre Medicament, |1225.81|4|0|0|C|3|3||0|0.39283|17596|1|
L01EC03|ENCORAFENIB|LH585|Braftovi|CAPSULE, HARD|50 mg|mg|28|1400|Pierre Fabre Medicament, |544.61|4|0|0|C|3|3||0|0.39283|17595|1|
L01EE03|BINIMETINIB|LH586|Mektovi|FILM-COATED TABLET|15 mg|mg|84|1260|Pierre Fabre Medicament, |1699.99|4|0|0|C|3|3||0|1.41121|17594|1|
L01EX14|ENTRECTINIB|LH587|Rozlytrek|CAPSULE, HARD|200 mg|mg|90|18000|Roche Registration GmbH, |5009.92|4|0|0|C|3|3||0|0.28533|17299|1|
L01FX14|POLATUZUMAB VEDOTIN|LH588|Polivy|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|140 mg|mg|1|140|Roche Registration GmbH, |10392.08|1|2|0|C|0|4||1|74.31317|17214|1|
L01FX14|POLATUZUMAB VEDOTIN|LH589|Polivy|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|30 mg|mg|1|30|Roche Registration GmbH, |2226.87|1|2|0|C|0|4||1|74.31317|18061|1|
L01FY01|PERTUZUMAB, TRASTUZUMAB|LH594|Phesgo|SOLUTION FOR INJECTION|1200 mg/600 mg - 15ml|mg|1|1800|Roche Registration GmbH, |4162.28|3|1|0|C|7|3||0|3.06697|18063|1|
L01FY01|PERTUZUMAB, TRASTUZUMAB|LH595|Phesgo|SOLUTION FOR INJECTION|600 mg/600 mg - 10 ml|mg|1|1200|Roche Registration GmbH, |2306.22|3|1|0|C|7|3||0|2.55285|18064|1|
L04AX04|LENALIDOMIDE|LH596|Lenalidomide Pharmascience|CAPSULE, HARD|15 mg|mg|21|315|Pharmascience International Ltd., |201.68|4|0|0|C|3|1||0|1.3142|17576|1|
L01EX01|SUNITINIB|LH597|Sunitinib Teva|CAPSULE, HARD|50 mg|mg|30|1500|Teva B.V, |436.76|4|0|0|C|3|3||0|0.39881|61749|1|
L01EX01|SUNITINIB|LH598|Sunitinib Teva|CAPSULE, HARD|25 mg|mg|30|750|Teva B.V, |218.38|4|0|0|C|3|3||0|0.39881|61742|1|
L01EX02|SORAFENIB|LH600|Sorafecon|FILM-COATED TABLET|200 mg|mg|112|22400| , |708.42|4|0|0|C|3|3||0|0.0316|58316|1|
L01CD04|CABAZITAXEL|LH601|Cabazitaxel Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 3ml|mg|1|60|Accord Healthcare S.L.U., |723.47|1|2|0|C|7|1||1|12.05177|77090|1|
L01CD04|CABAZITAXEL|LH602|Eleber|CONCENTRATE AND SOLVENT FOR SOLUTION FOR INFUSION|60 mg|mg|1|60|Zentiva k.s.,  |723.47|1|2|0|C|7|1||1|12.05177|27497|1|
L01EX01|SUNITINIB|LH608|Sunitinib Pharmascience|CAPSULE, HARD|50 mg|mg|30|1500|Pharmascience International Ltd., |436.76|4|0|0|C|3|3||0|0.39881|27563|1|
L01EX01|SUNITINIB|LH609|Sunitinib Pharmascience|CAPSULE, HARD|37.5 mg|mg|30|1125|Pharmascience International Ltd., |327.57|4|0|0|C|3|3||0|0.39881|27561|1|
L01EX01|SUNITINIB|LH610|Sunitinib Pharmascience|CAPSULE, HARD|12.5 mg|mg|30|375|Pharmascience International Ltd., |109.19|4|0|0|C|3|3||0|0.39881|27554|1|
L01EX01|SUNITINIB|LH611|Sunitinib Pharmascience|CAPSULE, HARD|25 mg|mg|30|750|Pharmascience International Ltd., |218.38|4|0|0|C|3|3||0|0.39881|27557|1|
L01EX01|SUNITINIB|LH612|Sunitinib Sandoz|CAPSULE, HARD|50 mg|mg|30|1500|Sandoz d.d., |436.76|4|0|0|C|3|3||0|0.39881|30292|1|
L01EX01|SUNITINIB|LH613|Sunitinib Sandoz|CAPSULE, HARD|25 mg|mg|30|750|Sandoz d.d., |218.38|4|0|0|C|3|3||0|0.39881|30311|1|
L01EX01|SUNITINIB|LH614|Sunitinib Sandoz|CAPSULE, HARD|12.5 mg|mg|30|375|Sandoz d.d., |109.19|4|0|0|C|3|3||0|0.39881|30273|1|
L04AX04|LENALIDOMIDE|LH615|Lenalidomide Grindeks|CAPSULE, HARD|5 mg|mg|21|105|AS Grindeks, |67.23|4|0|0|C|3|1||0|1.3142|17412|1|
L04AX04|LENALIDOMIDE|LH616|Lenalidomide Grindeks|CAPSULE, HARD|10 mg|mg|21|210|AS Grindeks, |134.46|4|0|0|C|3|1||0|1.3142|17413|1|
L04AX04|LENALIDOMIDE|LH617|Lenalidomide Grindeks|CAPSULE, HARD|25 mg|mg|21|525|AS Grindeks, |336.14|4|0|0|C|3|1||0|1.3142|17303|1|
L01FC01|DARATUMUMAB|LH619|Darzalex|SOLUTION FOR INJECTION|1800 mg-15 ml|mg|1|1800|Janssen-Cilag International N.V., |4931.26|3|1|0|C||4||0|2.78932|47299|1|
L01EX03|PAZOPANIB|LH620|Pazopanib Pharmascience|TABLETS FILM COATED|400 mg|mg|60|24000|Pharmascience International Ltd., |648.68|4|0|0|C|3|3||0|0.02761|58367|1|
L01EX03|PAZOPANIB|LH621|Pazopanib Pharmascience|TABLETS FILM COATED|200 mg|mg|30|6000|Pharmascience International Ltd., |162.17|4|0|0|C|3|3||0|0.02761|58353|1|
L01EX01|SUNITINIB|LH625|Sunitinib Accord|CAPSULE, HARD|25 mg|mg|30|750|Accord Healthcare S.L.U., |218.38|4|0|0|C|3|3||0|0.39881|54389|1|
L01EX01|SUNITINIB|LH626|Sunitinib Accord|CAPSULE, HARD|50 mg|mg|30|1500|Accord Healthcare S.L.U., |436.76|4|0|0|C|3|3||0|0.39881|54395|1|
L01EA01|IMATINIB|LH627|Imatinib Accord|TABLETS FILM COATED|100 mg|mg|120|12000|Accord Healthcare S.L.U., |81.96|4|0|0|C|3|3||0|0.00675|49028|1|
L01EX03|PAZOPANIB|LH628|Alunib|TABLETS FILM COATED|400 mg|mg|60|24000|  , |648.68|4|0|0|C|3|3||0|0.02761|58193|1|
L01EX03|PAZOPANIB|LH629|Alunib|TABLETS FILM COATED|200 mg|mg|30|6000|  , |162.17|4|0|0|C|3|3||0|0.02761|58186|1|
L01EX03|PAZOPANIB|LH630|Pazopanib Teva|TABLETS FILM COATED|400 mg|mg|60|24000|Teva B.V, |648.68|4|0|0|C|3|3||0|0.02761|58386|1|
L01XG01|BORTEZOMIB|LH634|Bortezomib Accord|SOLUTION FOR INJECTION|2.5 mg/ml - 1.4 ml|mg|1|3.5|Accord Healthcare S.L.U., |76.69|1|4|0|C||3||1|21.9076|46380|1|
L01XK04|TALAZOPARIB|LH635|Talzenna|CAPSULE, HARD|0.25 mg|mg|30|7.5|Pfizer Europe MA EEIG, |1041.98|4|0|0|C|3|3||0|138.88632|54552|1|
L01XK04|TALAZOPARIB|LH636|Talzenna|CAPSULE, HARD|1 mg|mg|30|30|Pfizer Europe MA EEIG, |4167.92|4|0|0|C|3|3||0|138.88632|54556|1|
L02BX03|ABIRATERONE ACETATE|LH639|Abiraterone Pharmascience|FILM-COATED TABLET|500 mg|mg|60|30000|Pharmascience International Ltd., |277.93|4|0|0|C|3|2||0|0.00926|58457|1|
L02BX03|ABIRATERONE ACETATE|LH645|Abiraterone Accord|TABLETS FILM COATED|500 mg|mg|60|30000|Accord Healthcare S.L.U., |277.93|4|0|0|C|3|2||0|0.00926|45181|1|
L01EM03|ALPELISIB|LH646|Piqray|FILM-COATED TABLET|200 mg|mg|28|5600|Novartis Europharm Ltd., |2053.37|4|0|0|C|3|3||0|0.39645|17372|1|
L01EM03|ALPELISIB|LH647|Piqray|FILM-COATED TABLET|150 mg|mg|56|8400|Novartis Europharm Ltd., |3079.51|4|0|0|C|3|3||0|0.39645|17409|1|
L01EM03|ALPELISIB|LH648|Piqray|FILM-COATED TABLET|50 mg + 200 mg|mg|56|7000|Novartis Europharm Ltd., |2565.89|4|0|0|C|3|3||0|0.39645|17371|1|
L01EX02|SORAFENIB|LH649|Sorafenib Teva|FILM-COATED TABLET|200 mg|MG|112|22400|Teva B.V, |708.42|4|0|0|C|3|3||0|0.0316|43962|1|
L01FD01|TRASTUZUMAB|LH650|Zercepac|CONCENTRATE FOR SOLUTION FOR INFUSION|150 mg|MG|1|150|Accord Healthcare S.L.U., |138.92|1|4|0|C||3||1|1.27181|55901|1|
L01EA02|DASATINIB|LH651|Dasatinib Zentiva|FILM-COATED TABLET|50 mg|MG|60|3000|Zentiva k.s.,  |964.28|4|0|0|C|3|3||0|0.31905|30499|1|
L01EA02|DASATINIB|LH652|Dasatinib Teva|FILM-COATED TABLET|50 mg|MG|30|1500|Teva B.V, |482.14|4|0|0|C|3|3||0|0.31905|31001|1|
L02BX03|ABIRATERONE ACETATE|LH653|Abiraterone STADA|FILM-COATED TABLET|500 mg|mg|60|30000|Stada Arzneimittel AG, |277.93|4|0|0|C|3|2||0|0.00926|58479|1|
L01FC02|ISATUXIMAB|LH654|Sarclisa|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 5 ml|mg|1|100|Sanofi Winthrop Industrie, |507.5|1|4|0|C||4||1|5.4544|53896|1|
L01FC02|ISATUXIMAB|LH655|Sarclisa|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 25 ml|mg|1|500|Sanofi Winthrop Industrie, |2537.52|1|4|0|C||4||1|5.4544|53898|1|
L01EX14|ENTRECTINIB|LH656|Rozlytrek|CAPSULE, HARD|100 mg|mg|30|3000|Roche Registration GmbH, |834.99|4|0|0|C|3|3||0|0.28533|53838|1|
L02BX03|ABIRATERONE ACETATE|LH657|Abiraterone Teva|TABLETS FILM COATED|500 mg|mg|60|30000|Teva B.V, |277.93|4|0|0|C|3|2||0|0.00926|59205|1|
L01EH03|TUCATINIB|LH658|Tukysa|TABLETS FILM COATED|50 mg|mg|88|4400|Pfizer Europe MA EEIG, |1666.44|4|0|0|C|3|3||0|0.37879|55072|1|
L01EH03|TUCATINIB|LH659|Tukysa|TABLETS FILM COATED|150 mg|mg|84|12600|Pfizer Europe MA EEIG, |4774.26|4|0|0|C|3|3||0|0.37879|55073|1|
L01FD04|TRASTUZUMAB DERUXTECAN|LH661|Enhertu|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg|mg|1|100|Daiichi Sankyo Europe GmbH, |1683.05|1|2|0|C||3||1|18.59671|47859|1|
L01XX73|SOTORASIB|LH662|Lumykras|TABLETS FILM COATED|120 mg|mg|240|28800|Amgen Eurpe B.V., |4623.29|4|0|0|C|3|3||0|0.16205|57357|1|
L01XY01|DAUNORUBICIN,CYTARABINE|LH663|Vyxeos liposomal|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|44 mg/100 mg|mg|1|144|Jazz Pharmaceuticals Ireland Limited, |5637.73|1|3|0|C|6|1||1|39.14747|55603|1|
L01AA09|BENDAMUSTINE HYDROCHLORIDE|LH664|Bendamustine Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|5|500|Accord Healthcare Polska , |198.13|1|4|0|C|6|1||1|0.41649|58806|1|
L01BC07|AZACITIDINE|LH665|Azacitidine STADA|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 150 mg)|MG|1|150|Stada Arzneimittel AG, |105.23|3|1|0|C||1||1|0.91087|59491|1|
L01FD01|TRASTUZUMAB|LH666|Herzuma|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|150 mg|mg|1|150|Celltrion Healthcare Hungary Kft., |138.92|1|4|0|C||3||1|1.27181|16309|1|
L01EA02|DASATINIB|LH667|Dasatinib Sandoz|FILM-COATED TABLET|50 mg|mg|60|3000|Sandoz d.d., |964.28|4|0|0|C|3|3||0|0.31905|30358|1|
L01FA01|RITUXIMAB|LH668|Ruxience|CONCENTRATE FOR SOLUTION FOR INFUSION|10 MG/ML - 10 ML|mg|1|100|Pfizer Europe MA EEIG, |62.52|1|4|0|C||3||1|0.62502|53844|1|
L01FA01|RITUXIMAB|LH669|Ruxience|CONCENTRATE FOR SOLUTION FOR INFUSION|500 mg (10 mg/ml-50 ml)|mg|1|500|Pfizer Europe MA EEIG, |312.58|1|4|0|C||3||1|0.62502|53845|1|
L01FG01|BEVACIZUMAB|LH670|VEGZELMA|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|mg|1|400|Celltrion Healthcare Hungary Kft., |314.21|1|4|0|C|8|3||1|1.20024|59910|1|
L01FG01|BEVACIZUMAB|LH671|VEGZELMA|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Celltrion Healthcare Hungary Kft., |79.93|1|4|0|C|8|3||1|1.20024|59909|1|
L01EL02|ACALABRUTINIB|LH672|Calquence|TABLETS FILM COATED|100 mg|mg|56|5600|Astra Zeneca AB, |6800.22|4|0|0|C|3|3||0|1.21432|60986|1|
L01CD04|CABAZITAXEL|LH673|Cabazitaxel Sandoz|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml - 6 ml|mg|1|60|Sandoz Pharmaceuticals d.d., |723.47|1|2|0|C|7|1||1|12.05177|26897|1|
L02BA03|FULVESTRANT|LH674|Fulvestrant Teva|SOLUTION FOR INJECTION|250 mg/5 ml|mg|2|500|Teva B.V, |117.31|2|1|0|C|8|2||0|0.29831|17225|1|
L01BC07|AZACITIDINE|LH675|Onureg|TABLETS FILM COATED|300 mg|MG|7|2100|Bristol-Myers Squibb Pharma EEIG, |7702.62|4|0|0|C|3|1||0|3.68654|51973|1|
L01EA06|ASCIMINIB|LH676|Scemblix|TABLETS FILM COATED|20 mg|MG|60|1200|Novartis Europharm Ltd., |2243.74|4|0|0|C|3|3||0|2.00988|60790|1|
L01EA06|ASCIMINIB|LH677|Scemblix|TABLETS FILM COATED|40 mg|MG|60|2400|Novartis Europharm Ltd., |4487.48|4|0|0|C|3|3||0|2.00988|60792|1|
L01EJ02|FEDRATINIB|LH678|Inrebic|CAPSULE, HARD|100 mg|MG|120|12000|Bristol-Myers Squibb Pharma EEIG, |3680.38|4|0|0|C|3|3||0|0.31399|49301|1|
L01EL03|ZANUBRUTINIB|LH679|Brukinsa|CAPSULE, HARD|80 mg|MG|120|9600|BeOne Medicines Ireland Ltd., |5286.11|4|0|0|C|3|3||0|0.56594|46483|1|
L01EN02|PEMIGATINIB|LH680|Pemazyre|TABLET|4.5 mg|MG|14|63|Incyte Biosciences Distribution B.V., |7428.85|4|0|0|C|3|3||0|117.87987|52144|1|
L01EX08|LENVATINIB|LH681|Lenvima|CAPSULE, HARD|10 mg|mg|30|300|Eisai GmbH, |1519.25|4|0|0|C|3|3||0|5.32879|50472|1|
L01EX08|LENVATINIB|LH682|Lenvima|CAPSULE, HARD|4 mg|mg|30|120|Eisai GmbH, |607.7|4|0|0|C|3|3||0|5.32879|17079|1|
L01FX12|TAFASITAMAB|LH685|Minjuvi|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|200 mg|MG|1|200|Incyte Biosciences Distribution B.V., |771.52|1|4|0|C||3||1|3.85382|51118|1|
L01FX13|ENFORTUMAB VEDOTIN|LH686|Padcev|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg|MG|1|20|Astellas Pharma Europe B.V., |524.23|1|4|0|C||3||1|26.19862|58828|1|
L01FX13|ENFORTUMAB VEDOTIN|LH687|Padcev|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|30 mg|MG|1|30|Astellas Pharma Europe B.V., |786.35|1|4|0|C||3||1|26.19862|58829|1|
L01FX17|SACITUZUMAB GOVITECAN|LH688|Trodelvy|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|200 mg|MG|1|200|Gilead Sciences Ireland UC, |1065.1|1|4|0|C||3||1|5.67617|55048|1|
L01FX18|AMIVANTAMAB|LH689|Rybrevant|CONCENTRATE FOR SOLUTION FOR INFUSION|350 mg|MG|1|350|Janssen-Cilag International N.V., |1427.06|1|4|0|C||3||0|4.07733|57352|1|
L01XX75|TEBENTAFUSP|LH690|Kimmtrak|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mcg/0.5 ml|MCG|1|100|Immunocore Ireland Limited, |11886.17|1|4|0|C||3||0|118.91647|58739|1|
L02BA03|FULVESTRANT|LH692|Imarsa|SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE|250 mg/5 ml|MG|2|500|Gedeon Richter Plc., |117.31|2|1|0|C|8|2||0|0.29831|17491|1|
L02BA03|FULVESTRANT|LH693|Vastaloma|SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE|250 mg/5 ml|mg|2|500|Zentiva k.s.,  |117.31|2|1|0|C|8|2||0|0.29831|17459|1|
L03AA13|PEGFILGRASTIM|LH697|Nyvepria|SOLUTION FOR INJECTION|6mg/0.6ml|mg|1|6|Pfizer Europe MA EEIG, |286.63|3|1|0|C|7|5||0|47.74952|51643|0|
L02BA03|FULVESTRANT|LH698|Fulvestrant Pharmascience|SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE|250 mg/5 ml|mg|2|500|Pharmascience International Ltd., |117.31|2|1|0|C|8|2||0|0.29831|17217|1|
L01EA02|DASATINIB|LH699|Dasatinib Teva|FILM-COATED TABLET|50 mg|MG|30|1500|Teva B.V, |482.14|4|0|0|C|3|3||0|0.31905|31001|1|
L01AA01|Cyclophosphamide|LH701|Cyclophosphamide Sandoz|CONCENTRATE FOR SOL. FOR INJECTION/INFUSION|100 mg/ml - 5 ml|mg|1|500|Sandoz d.d., |10.38|1|4|0|C|7|1||1|0.01779|64322|1|
L02BA03|FULVESTRANT|LH702|Fulvestrant Sandoz|SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE|250 mg/5 ml|mg|2|500|Sandoz d.d., |117.31|2|1|0|C|8|2||0|0.29831|17202|1|
L01FF05|ATEZOLIZUMAB|LH703|Tecentriq|SOLUTION FOR INJECTION|125 mg/ml - 15 ml|mg|1|1875|Roche Registration GmbH, |3958.12|3|1|0|C||4||0|2.10753|63590|1|
L01BC06|CAPECITABINE|LH704|Capecitacon|TABLETS FILM COATED|500 mg|mg|120|60000| , |57.28|4|0|0|C|3|1||0|0.00096|64295|1|
L01FG01|BEVACIZUMAB|LH705|Abevmy|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/ml - 4ml|mg|1|100|Biosimilar Collaborations Ireland Limited, |79.93|1|3|0|C|8|3||1|1.20024|45137|1|
L01FG01|BEVACIZUMAB|LH706|Abevmy|CONCENTRATE FOR SOLUTION FOR INFUSION|25mg/ml - 16ml|mg|1|400|Biosimilar Collaborations Ireland Limited, |314.21|1|3|0|C|8|3||1|1.20024|45139|1|
L01EA04|BOSUTINIB|LH707|Bosutinib Zentiva|TABLETS FILM COATED|100 mg|mg|28|2800|Zentiva k.s.,  |237.94|4|0|0|C|3|3||0|0.08498|64575|1|
L01BC07|AZACITIDINE|LH708|Azacitidine Accord|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 150 mg)|mg|1|150|Accord Healthcare S.L.U., |105.23|3|1|0|C||1||1|0.91087|58095|1|
L01EA03|NILOTINIB|LH710|Nilotinib Pharmascience|CAPSULE, HARD|150 mg|MG|28|4200|Pharmascience International Ltd., |229.55|4|0|0|C|3|3||0|0.05461|65539|1|
L01EA03|NILOTINIB|LH711|Nilotinib Pharmascience|CAPSULE, HARD|200 mg|MG|28|5600|Pharmascience International Ltd., |305.96|4|0|0|C|3|3||0|0.05461|65549|1|
L01CD01|PACLITAXEL|LH712|Apexelsin|POWDER FOR DISPERSION FOR INFUSION|5mg/ml (100mg)|mg|1|100|Whiteoak Pharmaceutical B.V., |154.63|1|3|0|C||1||1|1.38164|65663|1|
L01EA03|NILOTINIB|LH713|Nilotinib Zentiva|CAPSULE, HARD|150 mg|mg|112|16800|Zentiva k.s.,  |918.2|4|0|0|C|3|3||0|0.05461|65709|1|
L01EA03|NILOTINIB|LH714|Nilotinib Zentiva|CAPSULE, HARD|200 mg|mg|112|22400|Zentiva k.s.,  |1224.16|4|0|0|C|3|3||0|0.05461|65703|1|
L01FX25|MOSUNETUZUMAB|LH715|Lunsumio|CONCENTRATE FOR SOLUTION FOR INFUSION|1 mg/ml - 1 ml|mg|1|1|Roche Registration GmbH, |251.29|1|4|0|C||3||0|251.01|59186|1|
L01FX25|MOSUNETUZUMAB|LH716|Lunsumio|CONCENTRATE FOR SOLUTION FOR INFUSION|1 mg/ml - 30 ml|mg|1|30|Roche Registration GmbH, |7538.77|1|4|0|C||3||0|251.01|59187|1|
L01FX20|TREMELIMUMAB|LH717|Imjudo|CONCENTRATE FOR SOLUTION FOR INFUSION|300 mg/15 ml (20 mg/ml)|mg|1|300|Astra Zeneca AB, |14406.13|1|2|0|C||3||1|48.02025|62598|1|
L01EX19|RIPRETINIB|LH718|Qinlock|TABLET|50 mg|mg|90|4500|Deciphera Pharmaceuticals (Netherlands) B.V., |22012.98|4|0|0|C||3||0|4.89177|53011|1|
L01FX24|TECLISTAMAB|LH720|Tecvayli|SOLUTION FOR INJECTION|90 mg/ml - 1.7 ml|mg|1|153|Janssen-Cilag International N.V., |2596.73|3|4|0|C||3||1|33.27283|62628|1|
L01FX27|EPCORITAMAB|LH721|Tepkinly|SOLUTION FOR INJECTION|48 mg (60 mg/ml - 0.8 ml)|mg|1|48|AbbVie Deutschland GmbH & Co. KG, |6822.31|3|4|0|C||3||0|140.63329|63750|1|
L01FX28|GLOFITAMAB|LH722|Columvi|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/10 mg|mg|1|10|Roche Registration GmbH, |3720.13|1|4|0|C||3||0|371.298|64344|1|
L01FX28|GLOFITAMAB|LH723|Columvi|CONCENTRATE FOR SOLUTION FOR INFUSION|2.5 mg/2.5 ml (1 mg/ml)|mg|1|2.5|Roche Registration GmbH, |930.03|1|4|0|C||3||0|371.298|64339|1|
L01FX32|ELRANATAMAB|LH724|Elrexfio|SOLUTION FOR INJECTION|40 mg/ml - 1.9 ml|mg|1|76|Pfizer Europe MA EEIG, |6044.53|3|4|0|C||3||0|78.74318|63678|1|
L01FX32|ELRANATAMAB|LH725|Elrexfio|SOLUTION FOR INJECTION|40 mg/ml - 1.1 ml|mg|1|44|Pfizer Europe MA EEIG, |3499.46|3|4|0|C||3||1|78.74318|63676|1|
L01FY02|NIVOLUMAB,RELATLIMAB|LH726|Opdualag|CONCENTRATE FOR SOLUTION FOR INFUSION|240 mg/80 mg|mg|1|320|Bristol-Myers Squibb Pharma EEIG, |4380.4|1|1|0|C||3||0|15.50202|62603|1|
L01XK52|NIRAPARIB, ABIRATERONE|LH727|Akeega|TABLETS FILM COATED|50 mg/500 mg|mg|56|30800|Janssen-Cilag International N.V., |5526.11|4|0|0|C||8||0||63591|1|
L01XK52|NIRAPARIB, ABIRATERONE|LH728|Akeega|TABLETS FILM COATED|100 mg/500 mg|mg|56|33600|Janssen-Cilag International N.V., |5526.11|4|0|0|C||8||0||63592|1|
L01XX62|IVOSIDENIB|LH729|Tibsovo|TABLETS FILM COATED|250 mg|mg|60|15000|Les Laboratoires Servier, |12006.13|4|0|0|C||3||0|0.77116|61686|1|
L01XX62|IVOSIDENIB|LH730|Tibsovo|TABLETS FILM COATED|250 mg|mg|60|15000|Les Laboratoires Servier, |12006.13|4|0|0|C||3||0|0.7921|61686|1|
L01CD04|CABAZITAXEL|LH731|Cabazitaxel EVER Pharma|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml - 6 ml|mg|1|60|Ever Valinject GmbH, |723.47|1|2|0|C|7|1||1|12.05177|57732|1|
L01XX41|ERIBULIN|LH732|Eribulin EVER Pharma|SOLUTION FOR INJECTION|0.44mg/ml - 1 vial x 2ml|mg|1|0.88|Ever Valinject GmbH, |131.64|1|4|0|C||1||1|149.48954|65443|1|
L01XG01|BORTEZOMIB|LH733|Bortezomib EVER Pharma|SOLUTION FOR INJECTION|2.5 mg/ml - 1.4 ml|mg|1|3.5|Ever Valinject GmbH, |76.69|1|4|0|C||3||1|21.9076|60889|1|
L01XX41|ERIBULIN|LH734|Eribulin STADA|SOLUTION FOR INJECTION|0.44mg/ml - 1 vial x 2ml|mg|1|0.88|Stada Arzneimittel AG, |131.64|1|4|0|C||1||1|149.48954|64842|1|
L04AX06|POMALIDOMIDE|LH735|Pomalidomide Zentiva|CAPSULE, HARD|4 mg|mg|21|84|Zentiva k.s.,  |1974.29|4|0|0|C|3|1||0|23.49191|65622|1|
L02BA03|FULVESTRANT|LH736|Fulvestrant VER Pharma|SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE|250 mg/5 ml|mg|2|500|Ever Valinject GmbH, |117.31|2|1|0|C|8|2||0|0.29831|17525|1|
L01EA03|NILOTINIB|LH737|Nilotinib Accord|CAPSULE, HARD|150 mg|mg|112|16800|Accord Healthcare S.L.U., |918.2|4|0|0|C|3|3||0|0.05461|65990|1|
L01BC06|CAPECITABINE|LH738|Capecitabine Zentiva|FILM-COATED TABLET|500|mg|120|60000|Zentiva k.s.,  |57.28|4|0|0|C|3|1||0|0.00096|66091|1|
L01EA03|NILOTINIB|LH739|Nilotinib Stada|CAPSULE, HARD|150 mg|mg|28|4200|Stada Arzneimittel AG, |229.55|4|0|0|C|3|3||0|0.05461|65911|1|
L01EA03|NILOTINIB|LH740|Nilotinib Stada|CAPSULE, HARD|200 mg|mg|28|5600|Stada Arzneimittel AG, |305.96|4|0|0|C|3|3||0|0.05461|65943|1|
L04AX06|POMALIDOMIDE|LH741|Pomalidomide Grindeks|CAPSULE, HARD|4 mg|mg|21|84|AS Grindeks, |1974.29|4|0|0|C|3|1||0|23.49191|66489|1|
L01EK01|AXITINIB|LH742|Axitinib Accord|TABLETS FILM COATED|5 mg|mg|56|280|Accord Healthcare S.L.U., |1214.99|4|0|0|C|3|3||0|9.78993|66205|1|
L01AA01|Cyclophosphamide|LH743|Cyclophosphacon|POWDER FOR SOLUTION FOR INJECTION|500 mg|mg|1|500| , |10.38|1|4|0|C|7|1||1|0.01779|66633|1|
L01BC07|AZACITIDINE|LH744|Azaciticon|POWDER FOR SUSPENSION FOR INJECTION|25 mg/ml (1 vial x 100 mg)|mg|1|100| , |70.15|3|1|0|C||1||1|0.91087|66216|1|
L01EK01|AXITINIB|LH745|Axitinib Sandoz|TABLETS FILM COATED|5 mg|mg|60|300|Sandoz d.d., |1301.77|4|0|0|C|3|3||0|9.78993|61180|1|
L01EK01|AXITINIB|LH746|Axitinib Sandoz|TABLETS FILM COATED|1 mg|mg|60|60|Sandoz d.d., |260.35|4|0|0|C|3|3||0|9.78993|61175|1|
L04AX06|POMALIDOMIDE|LH747|Pomalidomide Accord|CAPSULE, HARD|4 mg|mg|21|84|Accord Healthcare S.L.U., |1974.29|4|0|0|C|3|1||0|23.49191|65651|1|
L01XX75|TEBENTAFUSP|LH748|Kimmtrak|CONCENTRATE FOR SOLUTION FOR INFUSION|100 mcg/0.5 ml|mcg|1|100|Immunocore Ireland Limited, |11886.17|1|4|0|C||3||0|118.91647|58739|1|
L01EK01|AXITINIB|LH749|Axitinib Teva|TABLETS FILM COATED|1 mg|mg|56|56|  , |243|4|0|0|C|3|3||0|9.78993|65251|1|
L01EK01|AXITINIB|LH750|Axitinib Teva|TABLETS FILM COATED|5 mg|mg|56|280|  , |1214.99|4|0|0|C|3|3||0|9.78993|65255|1|
L02BA03|FULVESTRANT|LH751|Fulvestrant Rompharm|SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE|250 mg/5 ml|mg|2|500|S.C.Rompharm Company S.R.L., |117.31|2|1|0|C|8|2||0|0.29831|26448|1|
L01CD04|CABAZITAXEL|LH753|Cabazitaxel EVER Pharma|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml - 4.5 ml|mg|1|45|Ever Valinject GmbH, |542.6|1|2|0|C|7|1||1|12.05177|57730|1|
L03AA13|PEGFILGRASTIM|LH754|Fulphila|SOLUTION FOR INJECTION|6 mg|mg|1|6|Biosimilar Collaborations Ireland Limited, |286.63|3|1|0|C|7|5||0|47.74952|48516|0|
L01CD01|PACLITAXEL|LH755|Naveruclif|POWDER FOR DISPERSION FOR INFUSION|5mg/ml (100mg)|mg|1|100|Accord Healthcare S.L.U., |154.63|1|3|0|C||1||1|1.38164|63607|1|
L01CD02|DOCETAXEL|LH756|Docecon|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 4 ml|mg|1|80| , |16.85|1|2|0|C||1||1|0.21237|67902|1|
L01XA02|CARBOPLATIN|LH757|Carbocon|CONCENTRATE FOR SOLUTION FOR INFUSION|10 mg/ml - 45 ml|mg|1|450| , |89.85|1|4|0|C||1||1|0.19961|68550|1|
L01EA02|DASATINIB|LH758|Dasatinib Zentiva|TABLETS FILM COATED|50 mg|mg|60|3000|Zentiva k.s.,  |964.28|4|0|0|C|3|3||0|0.31905|30499|1|
L01EX02|SORAFENIB|LH759|Sorafenib Pharmascience|TABLETS FILM COATED|200 mg|mg|112|22400|Pharmascience International Ltd., |708.42|4|0|0|C|3|3||0|0.06045|17302|1|
L01FX20|TREMELIMUMAB|LH760|Imjudo|CONCENTRATE FOR SOLUTION FOR INFUSION|25 mg/1.25 ml (20 mg/ml)|mg|1|25|Astra Zeneca AB, |1200.52|1|2|0|C||3||1|48.02025|62597|1|
L01XK04|TALAZOPARIB|LH761|Talzenna|CAPSULE, HARD|0.1 mg|mg|30|3|Pfizer Europe MA EEIG, |557.36|4|0|0|C|3|3||0|138.88632|63576|1|
L01XK04|TALAZOPARIB|LH762|Talzenna|CAPSULE, HARD|0.25 mg|mg|30|7.5|Pfizer Europe MA EEIG, |1393.39|4|0|0|C|3|3||0|138.88632|54552|1|
L04AC07|TOCILIZUMAB|LH763|RoActemra|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 4 ml|mg|1|80|Roche Registration GmbH, |89.69|1|4|0|C||8||1||3376|1|
L04AC07|TOCILIZUMAB|LH764|RoActemra|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 10 ml|mg|1|200|Roche Registration GmbH, |224.22|1|4|0|C||8||1||3377|1|
L04AC07|TOCILIZUMAB|LH765|RoActemra|CONCENTRATE FOR SOLUTION FOR INFUSION|20 mg/ml - 20 ml|mg|1|400|Roche Registration GmbH, |448.43|1|4|0|C||8||1||3378|1|
L02BA03|FULVESTRANT|LH766|Fulvecon|SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE|250 mg/5 ml|mg|2|250| , |117.31|2|1|0|C|8|2||0|0.29831|68548|1|
L01EK04|FRUQUINTINIB|LH767|Fruzaqla|CAPSULE, HARD|1 mg|mg|21|21|Takeda Pharmaceuticals International AG Ireland Branch, |961.23|4|0|0|C||3||0||65371|1|
L01EK04|FRUQUINTINIB|LH768|Fruzaqla|CAPSULE, HARD|5 mg|mg|21|105|Takeda Pharmaceuticals International AG Ireland Branch, |4806.13|4|0|0|C||3||0||65372|1|
L01EL05|PIRTOBRUTINIB|LH769|Jaypirca|TABLETS FILM COATED|100 mg|mg|28|2800|Eli Lilly Nederland B.V., |4768.21|4|0|0|C||3||0||63817|1|
L01EX21|TEPOTINIB|LH770|Tepmetko|TABLETS FILM COATED|225 mg|mg|60|13500|Merck Europe B.V., |9006.13|4|0|0|C||3||0||58112|1|
L01FF07|DOSTARLIMAB|LH771|Jemperli|CONCENTRATE FOR SOLUTION FOR INFUSION|50 mg/ml - 10 ml|mg|1|500|GlaxoSmithKline Traiding Services Ltd., |4411.92|1|1|0|C||4||0||49908|1|
L01FX26|MIRVETUXIMAB SORAVTANSINE|LH772|Elahere|CONCENTRATE FOR SOLUTION FOR INFUSION|50 mg/ml - 20 ml|mg|1|100|AbbVie Deutschland GmbH & Co. KG, |3442.86|1|1|0|C||3||1||66570|1|
L01FX29|TALQUETAMAB|LH774|Talvey|SOLUTION FOR INJECTION|40 mg/ml - 1 ml|mg|1|40|Janssen-Cilag International N.V., |3222.17|3|4|0|C||4||1||64366|1|
L01FX31|ZOLBETUXIMAB|LH775|Vyloy|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg (10 mg/ml - 10 ml)|mg|1|100|Astellas Pharma Europe B.V., |630.58|1|1|0|C||3||1||66188|1|
L01FX31|ZOLBETUXIMAB|LH776|Vyloy|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|300 mg|mg|1|300|Astellas Pharma Europe B.V., |1891.74|1|1|0|C||3||1||67381|1|
L01XK03|RUCAPARIB|LH777|Rubraca|TABLETS FILM COATED|300 mg|mg|60|18000|Pharmaand GmbH, |2289.29|4|0|0|C|3|3||0||53841|1|
L01XK03|RUCAPARIB|LH778|Rubraca|TABLETS FILM COATED|250 mg|mg|60|15000|Pharmaand GmbH, |2289.29|4|0|0|C|3|3||0||53840|1|
L01XK03|RUCAPARIB|LH779|Rubraca|TABLETS FILM COATED|200 mg|mg|60|12000|Pharmaand GmbH, |2289.29|4|0|0|C|3|3||0||53839|1|
L04AC11|SILTUXIMAB|LH780|Sylvant|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|100 mg|mg|1|100|Recordati Netherlands B.V., |533.11|1|1|0|C||8||1||54428|1|
L04AC11|SILTUXIMAB|LH781|Sylvant|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|400 mg|mg|1|400|Recordati Netherlands B.V., |2134.42|1|1|0|C||8||1||54429|1|
L01EX01|SUNITINIB|LH782|Sunitinib Zentiva|CAPSULE, HARD|50 mg|mg|30|1500|Zentiva k.s.,  |436.76|4|0|0|C|3|3||0|0.39881|17575|1|
L01EA03|NILOTINIB|LH783|Nilotinib Teva|CAPSULE, HARD|150 mg|mg|28|4200|  , |229.55|4|0|0|C|3|3||0|0.05461|68726|1|
L01EA03|NILOTINIB|LH784|Nilotinib Teva|CAPSULE, HARD|200 mg|mg|28|5600|  , |305.96|4|0|0|C|3|3||0|0.05461|68754|1|
L01EK01|AXITINIB|LH785|Axitinib Accord|TABLETS FILM COATED|1 mg|mg|56|56|Accord Healthcare S.L.U., |243|4|0|0|C|3|3||0|9.78993|66195|1|
L01BA04|PEMETREXED|LH786|Pemetrexed Novamed|POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION|500 mg|mg|1|500|  , |268.8|1|2|0|C|7|1||1|0.77921|16032|1|
L01EX03|PAZOPANIB|LH787|Pazopanib Zentiva|FILM-COATED TABLET|400 mg|mg|60|24000|Zentiva k.s.,  |648.68|4|0|0|C|3|3||0|0.02761|58332|1|
L01EF02|RIBOCICLIB|LH788|Kisqali|TABLETS FILM COATED|200 mg|mg|21|4200|Novartis Europharm Ltd., |822.66|4|0|0|C|3|3||0|0.20151|50174|1|
L01BC06|CAPECITABINE|LH789|Capecitabine Alupharma|TABLETS FILM COATED|500 mg|mg|120|60000|  , |57.28|4|0|0|C|3|1||0|0.00096|69694|1|
L01EA03|NILOTINIB|LH790|Nilotinib Pharmascience|CAPSULE, HARD|150 mg|mg|112|16800|Pharmascience International Ltd., |918.2|4|0|0|C|3|3||0|0.05461|65546|1|
L01EA03|NILOTINIB|LH791|Nilotinib Pharmascience|CAPSULE, HARD|200 mg|mg|112|22400|Pharmascience International Ltd., |1224.16|4|0|0|C|3|3||0|0.05461|65551|1|
M05BX04|DENOSUMAB|MH017|Xgeva|SOLUTION FOR INJECTION|120 MG/ 1.7 ML|mg|1|120|Amgen Eurpe B.V., |166.7|3|1|0|C|8|6||0|2.27689|1470|1|
M05BA08|ZOLEDRONIC ACID|MH022|Zolendronic acid Accord|CONCENTRATE FOR SOLUTION FOR INFUSION|4 MG/5 ML|mg|1|4|Accord Healthcare S.L.U., |11.71|1|4|0|C||6||0|2.92842|2866|1|
M05BA08|ZOLEDRONIC ACID|MH026|Zomtu|CONCENTRATE FOR SOLUTION FOR INFUSION|4 MG/5 ML|mg|1|4|   , |11.71|1|4|0|C||6||0|2.92842|43783|1|
M05BX04|DENOSUMAB|MH027|Osenvelt|SOLUTION FOR INJECTION|120 mg (70 mg/ml - 1.7 ml)|mg|1|120|Celltrion Healthcare Hungary Kft., |166.7|3|1|0|C|8|6||0|2.27689|67619|1|
M05BX04|DENOSUMAB|MH028|Wyost|SOLUTION FOR INJECTION|120 mg (70 mg/ml - 1.7 ml)|mg|1|120|Sandoz GmbH, |166.7|3|1|0|C|8|6||0|2.27689|66794|1|
M05BX04|DENOSUMAB|MH029|Yaxwer|SOLUTION FOR INJECTION|120 mg (70 mg/ml - 1.7 ml)|mg|1|120|Gedeon Richter Plc., |166.7|3|1|0|C|8|6||0|2.27689|68601|1|
M05BX04|DENOSUMAB|MH030|Vevzuo|SOLUTION FOR INJECTION|120 mg (70 mg/ml - 1.7 ml)|mg|1|120|Biosimilar Collaborations Ireland Limited, |166.7|3|1|0|C|8|6||0|2.27689|68607|1|
M05BX04|DENOSUMAB|MH031|Jubereq|SOLUTION FOR INJECTION|120 mg (70 mg/ml - 1.7 ml)|mg|1|120|Accord Healthcare S.L.U., |166.7|3|1|0|C|8|6||0|2.27689|68299|1|
M05BX04|DENOSUMAB|MH032|Enwylma|SOLUTION FOR INJECTION|120 mg (70 mg/ml - 1.7 ml)|mg|1|120|Zentiva k.s.,  |166.7|3|1|0|C|8|6||0|2.27689|69071|1|
N02AB02|Pethidine hydrochloride|NO588|LYDOL sol.for inj. 50 mg/ml- 2 ml x 10|solution for injection|50mg/ml-2ml|mg|10|1000| , |8.77|2|0|1|C||||0|0.00877|189|0|
N02AB03|FENTANYL|NO590|Victanyl|TRANSDERMAL PATCHES|75 mcg/h|mcg|5|375|Teva B.V, |18.11|4|0|1|C||||0|0.04786|2767|0|
N02AB03|FENTANYL|NO592|Victanyl|TRANSDERMAL PATCHES|50 mcg/h|mcg|5|250|Teva B.V, |12.07|4|0|1|C||||0|0.04786|1662|0|
N02AB03|FENTANYL|NO593|Victanyl|TRANSDERMAL PATCHES|100 mch/h|mcg|5|500|Teva B.V, |24.14|4|0|1|C||||0|0.04786|1663|0|
N02AA01|Morphine|NO597|MORPHINE SOPHARMA sol. inj. 20 mg/ml - 1 ml x 10|sol. inj.|20mg/ml-1ml|mg|10|200| , |7.55|2|0|1|C||||0|0.03771|142|0|
N02AA05|OXYCODONE|NO600|Oxycodone Actavis|CAPSULE, HARD|10 mg|mg|50|500|Teva B.V, |4.27|4|0|1|C||||0|0.00853|1809|0|
N02AA05|OXYCODONE|NO601|Oxycodone Actavis|CAPSULE, HARD|20 mg|mg|50|1000|Teva B.V, |8.53|4|0|1|C||||0|0.00853|1808|0|
N02AE01|BUPRENORPHINE|NO604|Buprenorphin Actavis|TRANSDERMAL PATCH|35 mcg/h|mcg|5|175|Teva B.V, |12.91|4|0|1|C||||0|0.07369|3508|0|
N02AE01|BUPRENORPHINE|NO605|Buprenorphin Actavis|TRANSDERMAL PATCH|52,5 mcg/h|mcg|5|262.5|Teva B.V, |19.36|4|0|1|C||||0|0.07369|2981|0|
N02AE01|BUPRENORPHINE|NO606|Buprenorphin Actavis|TRANSDERMAL PATCH|70 mcg/h|mcg|5|350|Teva B.V, |25.81|4|0|1|C||||0|0.07369|2187|0|
N02AA05|OXYCODONE|NO612|Oxycodone Actavis|TABL. RELEASE PROLONG|10 mg|mg|50|500|Teva B.V, |4.27|4|0|1|C||||0|0.00853|3053|0|
N02AA05|OXYCODONE|NO613|Oxycodone Actavis|TABL. RELEASE PROLONG|20 mg|mg|50|1000|Teva B.V, |8.53|4|0|1|C||||0|0.00853|3054|0|
N02AA05|OXYCODONE|NO614|Oxycodone Actavis|TABL. RELEASE PROLONG|40 mg|mg|50|2000|Teva B.V, |17.07|4|0|1|C||||0|0.00853|3055|0|
N02AA05|OXYCODONE|NO617|OXYLAN|PROLONGED-RELEASE TABLET|20 mg|mg|50|1000|G.L. Pharma GmbH, |8.53|4|0|1|C||||0|0.00853|3422|0|
N02AA05|OXYCODONE|NO618|OXYLAN|PROLONGED-RELEASE TABLET|40 mg|mg|50|2000|G.L. Pharma GmbH, |17.07|4|0|1|C||||0|0.00853|3423|0|
N02AA05|OXYCODONE|NO619|OXYLAN|PROLONGED-RELEASE TABLET|80 mg|mg|50|4000|G.L. Pharma GmbH, |34.14|4|0|1|C||||0|0.00853|3424|0|
N02AB03|FENTANYL|NO621|Vellofent|TABLETS SUBLINGUAL|133 mcg|mcg|4|532|   , |10.76|4|0|1|C||||0|0.02016|3234|0|
N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO627|Oxycodone/Naloxone Teva|TABL. RELEASE PROLONG|10mg/5mg|mg|50|500|Teva B.V, |13.69|4|0|1|C||||0|0.02728|16342|0|
N02AA55|OXYCODONE HYDROCHLORIDE/ NALOXONE HYDROCHLORIDE|NO628|Oxycodone/Naloxone Teva|TABL. RELEASE PROLONG|20mg/10mg|mg|50|1000|Teva B.V, |27.36|4|0|1|C||||0|0.02728|16343|0|
N02AB03|FENTANYL|NO633|Fentadolor|SUBLINGUAL TABLETS|100 mcg|mcg|10|1000|Sandoz d.d., |22.78|4|0|1|C||||0|0.02273|61915|0|
N02AB03|FENTANYL|NO634|Sublifen|SUBLINGUAL TABLETS|100 mcg|mcg|10|1000|G.L. Pharma GmbH, |22.78|4|0|1|C||||0|0.02273|57729|0|
N02AA08|DIHYDROCODEINE|NP414|DHC Continus|MODIFIED RELEASE TABL.|90 mg|mg|50|4500|Ennogen Healthcare (Europe) Ltd, |13.33|4|0|1|C||||0|0.00298|3617|0|
N02AX02|TRAMADOL|NP415|Tramalgin|SOLUTION FOR INJECTION|50 mg/ml - 2 ml|mg|10|1000| , |4.99|2|0|1|C||||0|0.00499|148|0|
N02AX02|TRAMADOL|NP419|Tramadol Stada|CAPSULES|50 mg|mg|30|1500|Stada Arzneimittel AG, |2.94|4|0|1|C||||0|0.00196|1583|0|
N02AX02|TRAMADOL|NP420|Tramalgin|CAPSULES|50 mg|mg|20|1000| , |1.96|4|0|1|C||||0|0.00196|800|0|
V03AC01|DEFEROXAMINE|VH009|DESFERAL|POWDER FOR SOLUTION FOR INFUSION|500 mg|mg|10|5000|Novartis Europharm Ltd., |25.48|1|4|0|C|1|||0|0.00509|2774|0|
V03AF03|CALCIUM FOLINATE|VH015|Bendafolin|SOL.FOR INJ|10mg/ml-100ml|mg|1|1000|Lyomark Pharma GmbH, Germany|61.49|1|0|0|C|0|1||1|0.06136|2573|1|
V03AF03|CALCIUM FOLINATE|VH016|Bendafolin|SOL.FOR INJ|10mg/ml-50ml|mg|1|500|Lyomark Pharma GmbH, Germany|30.73|1|0|0|C|0|1||1|0.06136|2574|1|
V03AF03|CALCIUM FOLINATE|VH018|Calcium folinate Sandoz|SOLUTION FOR INJECTION/INFUSION|10 MG/ML - 10 ML|mg|1|100|Sandoz d.d., |6.16|1|0|0|C|0|1||1|0.06136|15598|1|
V03AF03|CALCIUM FOLINATE|VH019|Calcium folinate Sandoz|SOLUTION FOR INJECTION/INFUSION|10 mg/ml - 5 ml|mg|5|250|Sandoz d.d., |15.38|1|0|0|C|0|1||1|0.06136|15618|1|
V03AF01|Mesna|VH021|UROMITEXAN|SOLUTION FOR INJECTION|100 mg/ml - 4 ml|mg|15|6000|  , |76.46|1|4|0|C|10|1||1|0.01229|4081|1|
V03AC03|DEFERASIROX|VH024|Deferasirox Pharmascience|FILM-COATED TABLET|180 mg|MG|30|5400|Pharmascience International Ltd., |29.51|4|0|0|C|3|||0|0.00546|27728|0|
V03AC03|DEFERASIROX|VH025|Deferasirox Teva|FILM-COATED TABLET|180 mg|MG|30|5400|  , |29.51|4|0|0|C|3|||0|0.00546|32132|0|
V03AC03|DEFERASIROX|VH027|Ferupantil|TABLETS FILM COATED|180 mg|mg|30|5400|Sandoz Pharmaceuticals d.d., |29.51|4|0|0|C|3|||0|0.00546|32147|0|
V03AC03|DEFERASIROX|VH032|Ziadex|TABLETS FILM COATED|360mg|mg|30|10800|  , |59.02|4|0|0|C|3|||0|0.00546|27078|0|
V03AC03|DEFERASIROX|VH033|Ziadex|TABLETS FILM COATED|180 mg|mg|30|5400|  , |29.51|4|0|0|C|3|||0|0.00546|27077|0|
V03AC03|DEFERASIROX|VH034|Deferasirox Pharmascience|DISPERSIBLE TABLET|250 mg|mg|28|7000|Pharmascience International Ltd., |27.3|4|0|0|C|3|||0|0.0039|28962|0|
V03AF03|CALCIUM FOLINATE|VH035|Folinic acid Kalceks|SOLUTION FOR INJECTION/INFUSION|10 MG/ML - 10 ML|mg|10|1000|AS KALCEKS, |61.49|1|0|0|C|0|1||1|0.06136|64693|1|
V03AF03|CALCIUM FOLINATE|VH036|Folinic acid Kalceks|SOLUTION FOR INJECTION/INFUSION|10mg/ml-50ml|mg|10|5000|AS KALCEKS, |307.37|1|0|0|C|0|1||1|0.06136|64699|1|
V03AF03|CALCIUM FOLINATE|VH037|Folinic acid Kalceks|SOLUTION FOR INJECTION/INFUSION|10mg/ml-100ml|mg|10|10000|AS KALCEKS, |614.78|1|0|0|C|0|1||1|0.06136|64701|1|
